<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Lipids</journal-id><journal-id journal-id-type="iso-abbrev">J Lipids</journal-id><journal-id journal-id-type="publisher-id">JL</journal-id><journal-title-group><journal-title>Journal of Lipids</journal-title></journal-title-group><issn pub-type="ppub">2090-3030</issn><issn pub-type="epub">2090-3049</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3346990</article-id><article-id pub-id-type="pmid">22577560</article-id><article-id pub-id-type="doi">10.1155/2012/304292</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>A Pleiotropic Role for the Orphan Nuclear Receptor Small Heterodimer Partner in Lipid Homeostasis and Metabolic Pathways</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Garruti</surname><given-names>Gabriella</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Helen H.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bonfrate</surname><given-names>Leonilde</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Bari</surname><given-names>Ornella</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>David Q.-H.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Portincasa</surname><given-names>Piero</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Section of Endocrinology, Department of Emergency and Organ Transplantations, University of Bari &#8220;Aldo Moro&#8221; Medical School, Piazza G. Cesare 11, 70124 Bari, Italy</aff><aff id="I2"><sup>2</sup>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Edward Doisy Research Center, Saint Louis University School of Medicine, 1100 S. Grand Boulevard, Room 205, St. Louis, MO 63104, USA</aff><aff id="I3"><sup>3</sup>Department of Biomedical Sciences and Human Oncology, Clinica Medica &#8220;A. Murri&#8221;, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy</aff><author-notes><corresp id="cor1">*Piero Portincasa: <email>p.portincasa@semeiotica.uniba.it</email></corresp><fn fn-type="other"><p>Academic Editor: B. A. Neuschwander-Tetri</p></fn></author-notes><pub-date pub-type="ppub"><year>2012</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2012</year></pub-date><volume>2012</volume><elocation-id>304292</elocation-id><history><date date-type="received"><day>8</day><month>8</month><year>2011</year></date><date date-type="accepted"><day>5</day><month>12</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#169; 2012 Gabriella Garruti et al.</copyright-statement><copyright-year>2012</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Nuclear receptors (NRs) comprise one of the most abundant classes of transcriptional regulators of metabolic diseases and have emerged as promising pharmaceutical targets. Small heterodimer partner (SHP; NR0B2) is a unique orphan NR lacking a DNA-binding domain but contains a putative ligand-binding domain. SHP is a transcriptional regulator affecting multiple key biological functions and metabolic processes including cholesterol, bile acid, and fatty acid metabolism, as well as reproductive biology and glucose-energy homeostasis. About half of all mammalian NRs and several transcriptional coregulators can interact with SHP. The SHP-mediated repression of target transcription factors includes at least three mechanisms including direct interference with the C-terminal activation function 2 (AF2) coactivator domains of NRs, recruitment of corepressors, or direct interaction with the surface of NR/transcription factors. Future research must focus on synthetic ligands acting on SHP as a potential therapeutic target in a series of metabolic abnormalities. Current understanding about the pleiotropic role of SHP is examined in this paper, and principal metabolic aspects connected with SHP function will be also discussed.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Nuclear receptors (NRs) constitute a unique family of ligand-modulated transcription factors. NRs mediate cellular response to small lipophilic endogenous and exogenous ligands [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>] and are responsible for sensing a number of hormones, including steroid and thyroid hormones, and act as positive and negative regulators of the expression of specific genes [<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>]. Therefore, NRs play a central role in many aspects of mammalian development, as well as lipid homeostasis, physiology, and metabolism. NRs make up one of the most abundant classes of transcriptional regulators in the body and have emerged as promising pharmaceutical targets.</p><p>Classically, NRs consist of several functional domains, that is, a variable N-terminal ligand-independent transactivation domain (which often exhibits a constitutive transcription activation function (AF-1)), a highly conserved DNA-binding domain (DBD) that contains two zinc fingers, a hinge domain (a variable linker region), and a multifunctional C-terminal domain. Furthermore, the C-terminal domain includes the ligand binding (LBD), the dimerization interface, and the ligand-dependent transactivation domain AF-2 [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>].</p><p>Small heterodimer partner (<italic>SHP</italic>; NR0B2 for nuclear receptor subfamily 0, group B, member 2; MIM number 604630, 601665) is a member of the mammalian NR superfamily, due to the presence of a putative ligand-binding domain (LBD) [<xref rid="B7" ref-type="bibr">7</xref>]. SHP functions as a corepressor through heterodimeric interaction with a wide array of nuclear receptors and repressing their transcriptional activity. SHP achieves its goal via several members of the NR superfamily that are able to regulate SHP expression. However, SHP is also a unique and atypical NR because it lacks the classical DNA-binding domain (DBD), generally present in other NRs [<xref rid="B8" ref-type="bibr">8</xref>]. The <italic>NR0B </italic>family of NRs consists of 2 orphan receptors: SHP and DAX-1 (dosage-sensitive sex reversal adrenal hypoplasia congenita (AHC) critical region on the X chromosome, gene 1). DAX1 is a gene whose mutation causes the X-linked adrenal hypoplasia congenita [<xref rid="B9" ref-type="bibr">9</xref>] and is the only family member that lacks a conventional DBD. DAX-1 (NR0B1) is therefore seen as the closest relative of SHP in the NR superfamily [<xref rid="B10" ref-type="bibr">10</xref>&#8211;<xref rid="B12" ref-type="bibr">12</xref>]. Both SHP and DAX-1 appear to be specific to vertebrates. In this respect, no homologous genes have been found in <italic>Drosophila melanogaster </italic>or <italic>Caenorhabditis elegans</italic> [<xref rid="B12" ref-type="bibr">12</xref>]. Whereas SHP is different from other conventional NRs both structurally and functionally, it acts as a ligand-regulated receptor in metabolic pathways [<xref rid="B13" ref-type="bibr">13</xref>]. SHP belongs to the orphan subfamily since there is no known ligand for this receptor, except for some retinoid-related molecules [<xref rid="B14" ref-type="bibr">14</xref>]. SHP inhibits transcriptional activation by working on several other nuclear receptors, that is, directly modulating the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>]. The discovery of SHP dates back to 1996 [<xref rid="B10" ref-type="bibr">10</xref>]; since then, this orphan NR has been identified as a key transcriptional regulator of signaling pathways [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B16" ref-type="bibr">16</xref>] involving fundamental biological functions and metabolic processes. Such processes include cholesterol, bile acid and fatty acid metabolism, glucose and energy homeostasis, and reproductive biology [<xref rid="B17" ref-type="bibr">17</xref>]. Experiments performed by fluorescence <italic>in situ </italic>hybridization (FISH) analysis of the human metaphase chromosome have shown that SHP is found at a single locus on chromosome 1 at position 1p36.1 and consists of two exons and a single intron spanning approximately 1.8 kb with 257 amino acids in humans [<xref rid="B18" ref-type="bibr">18</xref>]. In mice and rats, SHP resides on chromosomes 4 and 5, respectively, both consisting of 260 amino acids. SHP expression is predominantly observed in the liver [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B18" ref-type="bibr">18</xref>], but it is also detected at lower levels in other tissues, including the pancreas, spleen, small intestine, colon, gallbladder, kidney, adrenal gland, ovary, lung, brainstem, cerebellum, heart, and thymus (<xref ref-type="table" rid="tab1">Table 1</xref>) [<xref rid="B19" ref-type="bibr">19</xref>&#8211;<xref rid="B21" ref-type="bibr">21</xref>].</p><p>The genomic structure and human SHP domain structure are depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref> [<xref rid="B15" ref-type="bibr">15</xref>]. SHP is indeed able to repress the transcriptional activities of its target NRs and transcriptional regulators through two functional Leu-Xaa-Xaa-Leu-Leu- (LXXLL-) like motifs [<xref rid="B22" ref-type="bibr">22</xref>&#8211;<xref rid="B24" ref-type="bibr">24</xref>]. Such motifs appear to be essential for the interaction with the (activation function 2) AF-2 domains of several sets of NRs [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. The human SHP is enriched by another 12 amino acids [<xref rid="B128" ref-type="bibr">25</xref>&#8211;<xref rid="B139" ref-type="bibr">36</xref>], and this region between helix 6 and 7 is also involved in the repression of the transactivation of NRs [<xref rid="B25" ref-type="bibr">37</xref>].</p><p>About half of all mammalian NRs and several transcriptional coregulators can interact with SHP [<xref rid="B12" ref-type="bibr">12</xref>]. Since SHP lacks DNA-binding domain, it exerts the inhibitory effects through protein-protein interaction [<xref rid="B10" ref-type="bibr">10</xref>]. SHP expression seems to follow a circadian rhythm in the liver, involving the CLOCK-BMAL1 pathway and suggesting that some of the regulatory functions of SHP and deriving functions must be temporal [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B26" ref-type="bibr">38</xref>].</p><p>Gene expression of SHP is regulated by several factors including NRs, transcription factors, and a number of additional conditions and substances, as extensively reported in <xref ref-type="table" rid="tab2">Table 2</xref>. Also, the central role of SHP is clear since this NR is able to act as a coregulator for wide range of targets, namely, NRs/transcription factors/transcriptional coregulators and few different molecules, as depicted in <xref ref-type="table" rid="tab3">Table 3</xref>. In general, SHP acts as a repressor of the transcriptional activity of the specific interacting partner (via LBD of the partner and NR boxes of SHP) [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">39</xref>&#8211;<xref rid="B31" ref-type="bibr">43</xref>]. However, it is also demonstrated that SHP is able to upregulate gene transcription, as in the case of PPAR<italic>&#945;</italic> and PPAR<italic>&#947;</italic> [<xref rid="B32" ref-type="bibr">44</xref>&#8211;<xref rid="B34" ref-type="bibr">46</xref>] and NF-<italic>&#954;</italic>B [<xref rid="B32" ref-type="bibr">44</xref>].</p><p>Both N-terminal NR interaction domain and C-terminal domain of SHP are important for repression [<xref rid="B35" ref-type="bibr">47</xref>, <xref rid="B36" ref-type="bibr">48</xref>]. Overall, the SHP-mediated repression of target transcription factors occurs by at least three distinct transcriptional repression mechanisms (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>A first mechanism involves direct interference with the AF-2 coactivator domain of NRs (competition for coactivator binding, leading to the repression of NR-mediated transcriptional activity). This is the case for the inhibition of estrogen receptor <italic>&#945;</italic> (ER<italic>&#945;</italic>) and estrogen receptor <italic>&#946;</italic> (ER<italic>&#946;</italic>) [<xref rid="B37" ref-type="bibr">49</xref>].</p><p>A second mechanism for the SHP-mediated repression involves the recruitment of corepressors including direct interactions among mammalian homolog of the <italic>Saccharomyces cerevisiae</italic> transcriptional corepressor Sin3p (mSin3A), human Brahma (Brm), SWItch/Sucrose NonFermentable (SWI/SNF) complexes leading to the repression of cholesterol 7<italic>&#945;</italic>-hydroxylase (CYP7A1) [<xref rid="B38" ref-type="bibr">50</xref>]).</p><p>A third mechanism of inhibition of SHP involves the direct interaction with the surface of NR or transcription factor, resulting in the blockade of DNA binding and the consequent inhibition of its transcriptional activity. This is the case for RAR-RXR heterodimers [<xref rid="B10" ref-type="bibr">10</xref>], PXR-RXR binding to DNA by SHP [<xref rid="B1" ref-type="bibr">1</xref>], interaction with hepatocyte nuclear factor (HNF4), or Jun family of the activator protein 1 (AP-1) transcription factor complex (JunD) [<xref rid="B39" ref-type="bibr">51</xref>, <xref rid="B40" ref-type="bibr">52</xref>].</p><p>All three mechanisms might occur sequentially or alternatively according to type of cells and promoters [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>Clearly, information on factors that increase or decrease SHP expression and that are regulated by SHP is essential for understanding the regulatory effects of this orphan NR. Few years of research have not been enough to identify a true ligand. Interestingly, it is suggested that targeting posttranslational modifications of SHP may be an effective therapeutic strategy. Selected groups of genes could be controlled to cure a vast range of metabolic and SHP-related diseases [<xref rid="B41" ref-type="bibr">53</xref>]. Overall, the huge amount of information on SHP function is currently available, making this NR essential in a number of functions involving cholesterol and bile acid metabolism, lipogenesis, glucose metabolism, steroid hormone biosynthesis, xenobiotic homeostasis/metabolism, and cell cycle.</p><p>In particular, the ability of SHP in interacting with different metabolic signaling pathways including bile acids and lipid homeostasis, fat mass, adipocytes, and obesity will be reviewed here. </p></sec><sec id="sec2"><title>2. Bile Acids and Lipid Homeostasis</title><p>The wide ability of SHP to target multiple genes in diverse signaling pathways points to the key role of SHP in various biological processes, including the metabolism of bile salts, glucose, and fatty acids. Both unique structure and functional properties account for the complexity of SHP signaling. Studies suggest that loss of SHP might positively affect cholesterol and bile acid homeostasis in pathophysiologically relevant conditions [<xref rid="B42" ref-type="bibr">54</xref>]. Bile acids (BAs) are amphipatic cholesterol metabolites which are synthesized in the liver, secreted into bile, stored in the gallbladder, and secreted postprandially into the duodenum. BAs are synthesized from cholesterol, and this pathway provides the elimination of excess cholesterol in the body [<xref rid="B43" ref-type="bibr">55</xref>]. Moreover, BAs should be seen as physiological detergents which, in the small intestine, are essential for the absorption, transport, and distribution of lipophilic molecules, including dietary lipids, steroids, and lipid-soluble vitamins. In the intestine, BAs undergo extensive metabolism by the intestinal microflora. A high efficient system is the enterohepatic circulation of BAs [<xref rid="B43" ref-type="bibr">55</xref>, <xref rid="B44" ref-type="bibr">56</xref>], where more than 90&#8211;95% of BAs are returned to the liver from the terminal ileum via the portal vein. Thus, the concentration of BAs in serum, liver, and intestine is tightly regulated to prevent damage to enterohepatic tissues due to their strong detergent moiety [<xref rid="B45" ref-type="bibr">57</xref>&#8211;<xref rid="B47" ref-type="bibr">59</xref>]. The major rate-limiting step in biosynthetic pathway of BAs in humans is initiated by cholesterol 7<italic>&#945;</italic>-hydroxylase (CYP7A1), the microsomal P450 liver enzyme, to produce two primary BAs, cholic acid, and chenodeoxycholic acid, essential in the overall balance of cholesterol homeostasis. Sterol 12<italic>&#945;</italic> hydroxylase (CYP8B1) catalyzes the synthesis of cholic acid, a step which determines the cholic acid to CDCA ratio in the bile [<xref rid="B48" ref-type="bibr">60</xref>]. Secondary bile acids (deoxycholic acid and lithocholic acid) and tertiary bile acids (ursodeoxycholic acid) in humans are produced following intestinal dehydroxylation of primary bile acids by intestinal bacteria [<xref rid="B46" ref-type="bibr">58</xref>, <xref rid="B49" ref-type="bibr">61</xref>].</p><p>Regulation of BA biosynthesis is highly coordinated and is mediated by key NRs including the orphan receptor, liver receptor homologue-1 (LRH1; NR5A2), the hepatocyte nuclear factor 4<italic>&#945;</italic> (HNF4<italic>&#945;</italic>), SHP, and the bile acid receptor farnesoid X receptor (FXR; NR1H4). Thus, the activation of FXR initiates a feedback regulatory loop via induction of SHP, which suppresses LRH-1- and HNF4<italic>&#945;</italic>-dependent expression of the two major pathway enzymes cholesterol 7hydroxylase (CYP7A1) and sterol 12 hydroxylase (CYP8B1).</p><p>The BA feedback regulation primarily occurs since BAs act as transcriptional regulators for the expression of the gene encoding CYP7A1. Both cholic acid and chenodeoxycholic acid function as endogenous ligands for the nuclear bile acid receptor FXR [<xref rid="B50" ref-type="bibr">62</xref>]. FXR expression is high in the intestine and liver, the two sites where BAs reach high concentrations to activate FXR. The transcription by FXR includes heterodimerization with retinoid X receptors (RXRs) in the cytoplasm, translocation into the nucleus, and binding to DNA response elements in the regulatory regions of target genes [<xref rid="B51" ref-type="bibr">63</xref>]. When the bind of BAs to FXR, SHP transcription is increased [<xref rid="B48" ref-type="bibr">60</xref>, <xref rid="B52" ref-type="bibr">64</xref>, <xref rid="B53" ref-type="bibr">65</xref>], this alteration leads to the inhibition of LRH-1 activity or HNF4<italic>&#945;</italic> on the BA response elements (BAREs) of CYP7A1 and CYP8B1 promoters [<xref rid="B52" ref-type="bibr">64</xref>, <xref rid="B53" ref-type="bibr">65</xref>]. In this scenario, BA synthesis is downregulated by a precise feedback regulatory mechanism, which represents the major pathway under normal physiological conditions [<xref rid="B52" ref-type="bibr">64</xref>&#8211;<xref rid="B54" ref-type="bibr">66</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>). LRH1 is also a well-known activator of <italic>Shp</italic> gene transcription [<xref rid="B52" ref-type="bibr">64</xref>, <xref rid="B53" ref-type="bibr">65</xref>], and this step leads to an autoregulatory loop of gene expression by SHP [<xref rid="B30" ref-type="bibr">42</xref>]. This step also includes the G protein pathway suppressor 2 (GPS2) interacting with FXR, LRH-1, and HNF4<italic>&#945;</italic> to regulate CYP7A1 and CYP8B1 expression in human hepatocytes [<xref rid="B55" ref-type="bibr">67</xref>] (<xref ref-type="table" rid="tab3">Table 3</xref>). A critical role in maintaining cholesterol homeostasis for CYP7A1 has been recently advocated in a model of in Cyp7a1-tg mice [<xref rid="B56" ref-type="bibr">68</xref>].</p><p>The hepatocyte nuclear factor-1<italic>&#945;</italic> (HNF1<italic>&#945;</italic>), which haploinsufficiency causes the Maturity-onset diabetes of the young type 3 (MODY3), also appears to modulate SHP expression via the FXR pathway. In this respect, HNF1<italic>&#945;</italic> (&#8722;/&#8722;) mice displayed a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism [<xref rid="B57" ref-type="bibr">69</xref>].</p><p>A role for SHP in mediating the recruitment of mSin3A-Swi/Snf to the CYP7A1 promoter, with chromatin remodeling and gene repression, has been described. In HepG2 cells, Kemper et al. [<xref rid="B38" ref-type="bibr">50</xref>] have shown that bile acid treatment resulted in SHP-mediated recruitment of transcriptional coregulators mSin3A and Swi/Snf complex to the promoter, chromatin remodeling, and gene repression (<xref ref-type="table" rid="tab3">Table 3</xref>). This is an additional mechanism involving transformation of nucleosome conformation for the repression by SHP of genes activated by various NRs. In line with such results, increased synthesis and accumulation of BAs occurs in SHP (&#8722;/&#8722;) mice, due to the loss of SHP repression and consequent derepression of the rate-limiting CYP7A1 and cholesterol 12<italic>&#945;</italic>-hydroxylase (CYP8B1) (the rate-determining enzyme of the alternative but minor BA synthesis pathway) in the biosynthetic pathway [<xref rid="B58" ref-type="bibr">70</xref>&#8211;<xref rid="B60" ref-type="bibr">72</xref>].</p><p>Mechanisms independent of the FXR/SHP/LRH pathway might also exist, since BAs feeding to SHP (&#8722;/&#8722;) mice reduced the levels of CYP7A1 mRNA to similar levels of control mice [<xref rid="B58" ref-type="bibr">70</xref>, <xref rid="B59" ref-type="bibr">71</xref>]. Such SHP-independent and alternative pathways include the protein kinase C/Jun N-terminal kinase (PKC/JNK) pathway [<xref rid="B61" ref-type="bibr">73</xref>], the FXR/FGFR4 (FGF receptor 4) pathway [<xref rid="B45" ref-type="bibr">57</xref>, <xref rid="B62" ref-type="bibr">74</xref>], the cytokine/JNK pathway [<xref rid="B63" ref-type="bibr">75</xref>], the pregnane X receptor (PXR) mediated pathway [<xref rid="B64" ref-type="bibr">76</xref>], and the JNK/c-Jun signaling pathway [<xref rid="B65" ref-type="bibr">77</xref>].</p><p>Another study demonstrated, in SHP (&#8722;/&#8722;) mice on a background of 129 strain, the protection against hypercholesterolemia in three different models: an atherogenic diet, hypothyroidism, and SHP (&#8722;/&#8722;) mice intercrossed with LDLR (&#8722;/&#8722;) mice (to generate SHP/LDLR double (&#8722;/&#8722;) mice in a mixed 129-C57BL/6 background). When fed an atherogenic diet, the latter strain was almost completely resistant to diet-mediated increases in triglyceride, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol but had an increase in high-density lipoprotein (HDL) cholesterol as compared with LDLR (&#8722;/&#8722;) mice. Such results point to the protection against dyslipidemia following the inhibition of hepatic SHP expression, although no antagonist ligands have yet been identified for SHP [<xref rid="B66" ref-type="bibr">78</xref>]. We have recently examined biliary lipid secretion and cholesterol gallstone formation in male SHP (&#8722;/&#8722;) and (+/+) mice before and during the feeding of a lithogenic diet for 56 days [<xref rid="B67" ref-type="bibr">79</xref>]. Deletion of the <italic>Shp</italic> gene significantly increased hepatic bile salt synthesis, and doubled the increase of biliary bile salt outputs in SHP (&#8722;/&#8722;) mice than in (+/+) mice. The intestinal bile acid pool size was significantly greater in SHP (&#8722;/&#8722;) mice than in (+/+) mice. These increased BAs are efficacious ligands of FXR and can stimulate the expression of intestinal fibroblast growth factor 15 (FGF15) in mice through the FXR signaling pathway, which is consistent with the expanded bile acid pool size in SHP (&#8722;/&#8722;) mice. At 14 days on the lithogenic diet, fasting gallbladder volume was significantly larger in SHP (+/+) mice than in (&#8722;/&#8722;) mice [<xref rid="B68" ref-type="bibr">80</xref>].</p><p>Indeed, FGF15/19 (mouse and human orthologs, resp.) is another FXR gene target in the intestine and appears to contribute to the fine tuning of bile acid synthesis in the liver. Thus, a model for FXR-mediated repression of bile acid synthesis should also take into account the bile acid-mediated activation of intestinal FXR and FGF15 in the small intestine (while the FXR-SHP pathway is activated in the liver). According to the most plausible view, FGF15 acts as a hormone to signal between intestine and liver. The secreted FGF15 by the intestine circulates to the liver, likely through the portal circulation or lymph flow [<xref rid="B69" ref-type="bibr">81</xref>], and induces the activation of FGFR4 in the liver. As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, the FGF15/FGFR4 pathway synergizes with SHP <italic>in vivo</italic> to repress CYP7A1 expression [<xref rid="B45" ref-type="bibr">57</xref>]. In humans, a similar mechanism should involve the FGF19. Of note, activation of FXR transcription in the intestine protected the liver from cholestasis in mice by inducing FGF15 expression and reducing the hepatic pool of BA. This suggests a potential approach to reverse cholestasis in patients [<xref rid="B70" ref-type="bibr">82</xref>]. Hepatic fatty acid homeostasis is also regulated by SHP since regulating these genes involves in fatty acid uptake, synthesis, and export [<xref rid="B71" ref-type="bibr">83</xref>&#8211;<xref rid="B75" ref-type="bibr">87</xref>]. In a study exploring global gene expression profiling combined with chromatin immunoprecipitation assays in transgenic mice constitutively expressing SHP in the liver, overexpression of <italic>SHP </italic>in the liver was associated with the depletion of the hepatic bile acid pool and a concomitant accumulation of triglycerides in the liver [<xref rid="B72" ref-type="bibr">84</xref>]. By contrast, fat accumulation induced by a high-cholesterol or high-fat diet is prevented by the deletion of <italic>SHP </italic>[<xref rid="B76" ref-type="bibr">88</xref>, <xref rid="B77" ref-type="bibr">89</xref>]. The pleiotropic role of SHP can also be found in the case of nonalcoholic liver steatosis since <italic>OB</italic>/<italic>SHP </italic>double (&#8722;/&#8722;) mice (a model of severe obesity and insulin resistance) became resistant to liver steatosis and showed improved insulin sensitivity [<xref rid="B74" ref-type="bibr">86</xref>].</p><p>Another interesting role for SHP emerged after it was found that BAs negatively regulate the human angiotensinogen (ANG) gene. ANG is the precursor of vasoactive octapeptide angiotensin II, and BAs act through the SHP pathway by preventing hepatocyte nuclear factor-4 (HNF4) from binding to the human ANG promoter [<xref rid="B78" ref-type="bibr">90</xref>].</p></sec><sec id="sec3"><title>3. Fat Mass, Adipocytes, and Obesity</title><p>SHP appears to play a central role in obesity. Human obesity is considered a polygenic disorder characterized by partly known abnormal molecular mechanisms resulting in increased fat mass, with an imbalance between the energy acquired from nutrients that dissipated as heat (i.e., thermogenesis). In this respect, weight stability requires a balance between calories consumed and calories expended [<xref rid="B79" ref-type="bibr">91</xref>]. In adipose tissue depots, two main types of adipocytes exist, that is, brown adipocytes and white adipocytes. In several animal species, some adipose tissue sites mainly include brown adipocytes (BATs) and the other contains mainly white adipocytes (WATs). BAT dissipates chemical energy to produce heat either as a defense against cold [<xref rid="B80" ref-type="bibr">92</xref>] or as energy expenditure to compensate food intake [<xref rid="B81" ref-type="bibr">93</xref>, <xref rid="B82" ref-type="bibr">94</xref>]. The unusual function of BAT might be better understood by considering that they share a common origin with myocytes [<xref rid="B83" ref-type="bibr">95</xref>, <xref rid="B84" ref-type="bibr">96</xref>], and BAT was indeed considered something in between muscle and adipose tissue [<xref rid="B83" ref-type="bibr">95</xref>]. BAT is deemed as the major site for sympathetic (adrenergic) mediated adaptive thermogenesis; this pathway involves the uncoupling protein-1 (UCP1). WAT is mainly implicated in the regulation of lipid storage and catabolism but also in the synthesis and secretion of adipokines [<xref rid="B85" ref-type="bibr">97</xref>&#8211;<xref rid="B88" ref-type="bibr">100</xref>]. While the percentage of young men with BAT is high, the activity of BAT is reduced in men who are overweight or obese [<xref rid="B89" ref-type="bibr">101</xref>]. Thermogenesis unequivocally exists in both humans and animals, and BAT is the major site of thermogenesis which can be increased by environmental factors (i.e., adaptive thermogenesis). In both human and animal species, dietary composition, chronic cold exposure, and exercise may increase thermogenesis [<xref rid="B90" ref-type="bibr">102</xref>]. As far as adipose tissue biology is concerned, SHP seems to play a distinct regulatory function in WAT, as compared with BAT. A number of experiments have focused on animal models of obesity and subtle molecular changes. SHP-deficient mice are protected against high-fat-diet-induced obesity [<xref rid="B77" ref-type="bibr">89</xref>].</p><p>Peroxisome proliferator-activated receptor (PPAR) <italic>&#947;</italic> coactivator-1 (PGC-1) family members are multifunctional transcriptional coregulators. PGC-1 acts as a molecular switch in several metabolic pathways. In particular, PGC-1<italic>&#945;</italic> and PGC-1<italic>&#946;</italic> regulate mitochondrial biogenesis, adaptive thermogenesis, fatty acid and glucose metabolism, fiber-type switching in skeletal muscle, peripheral circadian clock, and development of the heart [<xref rid="B91" ref-type="bibr">103</xref>]. In particular, SHP functions as a negative regulator of energy production in BAT [<xref rid="B77" ref-type="bibr">89</xref>] because SHP is a negative regulator of PGC-1<italic>&#945;</italic> expression in BAT. In turn, PCG-1<italic>&#945;</italic> is a coactivator of uncoupling protein 1 (UCP1) which plays a major role in energy dissipation as heat in multilocular BAT of different animal species and humans [<xref rid="B92" ref-type="bibr">104</xref>&#8211;<xref rid="B94" ref-type="bibr">106</xref>]. Fat-specific (BAT) SHP-overexpressed transgenic mice had increased body weight and adiposity. Energy metabolism, however, was increased, and BAT cold exposure function was enhanced with activation of thermogenic genes and mitochondrial biogenesis (enhanced <italic>&#946;</italic>1-AR gene expression and PGC1<italic>&#945;</italic>). Compared with wild-type mice on a high-fat diet, SHP overexpression was associated with enhanced diet-induced obesity phenotype with weight gain, increased adiposity, and severe glucose intolerance. An additional feature of SHP transgenic mice was a decreased diet-induced adaptive thermogenesis, increased intake of food, and decreased physical activity [<xref rid="B95" ref-type="bibr">107</xref>]. This leads to the conclusion that, although expressed at low levels in fat, activation of SHP in adipocytes has a strong effect on weight gain and diet-induced obesity [<xref rid="B95" ref-type="bibr">107</xref>]. Moreover, if mechanisms linked to energy metabolism and the development of obesity are considered, SHP has distinct roles in WAT and BAT. As previously mentioned, while <italic>SHP</italic> deletion in obese leptin-deficient mice (<italic>ob/ob</italic>) prevented the development of nonalcoholic fatty liver and improved peripheral insulin sensitivity [<xref rid="B74" ref-type="bibr">86</xref>], <italic>SHP</italic> deletion did not overcome the severe obesity caused by leptin deficiency. A significant protective effect from obesity by <italic>SHP</italic> deficiency was likely associated with the low basal level of SHP expressed in fat. Adipogenesis appears to be influenced by SHP: when SHP was overexpressed in 3T3-L1 preadipocytes, cell differentiation was inhibited, as well as the accumulation of neutral lipids within the cells. Thus, SHP may act as a molecular switch governing adipogenesis. In particular, SHP appears to be a potent adipogenic suppressor, and preadipocytes are kept in an undifferentiated state through the inhibition of the adipogenic transcription factors and stimulators [<xref rid="B96" ref-type="bibr">108</xref>]. Further studies will address whether the loss of <italic>SHP </italic>function results in inhibition of lipid accumulation in adipocytes, similar to what is observed in hepatocytes. In a future clinical setting, treatment of obesity might also include drugs able to mimic or stimulate the effects of SHP. Mutations in the <italic>Shp</italic> gene have also been reported in patients with lipodystrophy carrying four different polymorphisms [<xref rid="B97" ref-type="bibr">109</xref>].</p><p>SHP mutations may not be considered a common cause of severe obesity. A number of important clinical studies have examined this issue (<xref ref-type="table" rid="tab4">Table 4</xref>); however, Hung et al. [<xref rid="B98" ref-type="bibr">110</xref>] in UK examined the relationships between genetic variation in <italic>SHP</italic> and weight at birth, adiposity, and insulin levels in three different populations (the Genetics of Obesity Study) GOOS, the Avon Longitudinal Study of Parents and Children (ALSPAC), and the Ely studies). In the 329 cases of severe early-onset obesity (GOOS study), two novel and rare missense mutations (R34G and R36G) were identified which might in part contribute to obesity in the probands. Furthermore, two common polymorphisms, namely, G171A (12% of subjects with higher birth weight) and &#8722;195CTGAdel (16% of subjects with lower birth weight) were found. In the ALSPAC cohort of 1,079 children, the G171A variant was associated with increased body mass index and waist circumference together with higher insulin secretion 30 minutes after glucose load. Thus, whereas mutations in the <italic>Shp</italic> gene cannot be seen as a common cause of severe human obesity, genetic variation in the <italic>Shp</italic> gene locus may influence birth weight and have effects on body size. The effect might ultimately involve insulin secretion by the negative regulation between SHP and the hepatocyte nuclear factor-4<italic>&#945;</italic> (HFN-4<italic>&#945;</italic>), a transcription factor involved in differentiation and function of pancreatic <italic>&#946;</italic>-cells [<xref rid="B98" ref-type="bibr">110</xref>].</p><p>A possibility is that decreased <italic>SHP</italic> expression or function results in increased HFN-4<italic>&#945;</italic> activity with a cascade of events, including fetal hyperinsulinemia, and increased birth weight. At a later stage, sustained hyperinsulinemia might be responsible of insulin resistance and obesity of the adult [<xref rid="B98" ref-type="bibr">110</xref>].</p><p>Mutations in the <italic>Shp</italic> gene were also associated with influence on birth weight, mild obesity, and insulin levels in the study by Nishigori et al. on 274 Japanese subjects [<xref rid="B99" ref-type="bibr">111</xref>]. Mutations in several genes encoding transcription factors of the hepatocyte nuclear factor (HNF) cascade are associated with maturity-onset diabetes of the young (MODY). MODY is a monogenic form of early-onset diabetes mellitus (defective insulin secretion with normal body weight), and SHP is deemed as a plausible candidate MODY gene; this is because SHP is able to inhibit the transcriptional activity of the hepatocyte nuclear factor-4<italic>&#945;</italic> (HFN-4<italic>&#945;</italic>), a key member of the MODY regulatory network. Thus, further studies have looked for segregation of <italic>SHP</italic> mutations with MODY in a cohort of Japanese patients with early-onset diabetes. In this context, variants in <italic>SHP</italic> appeared to cosegregate with increased body mass index in families, thus contributing to obesity among Japanese subjects. Also, increased risk of morbidity was observed in another study from Japan, examining patients with type 2 diabetes and <italic>SHP</italic> mutations [<xref rid="B100" ref-type="bibr">112</xref>].</p><p>Major differences, however, might exist in the prevalence and function of <italic>SHP</italic> variants in different populations. Of note, the results from other Caucasian cohorts did not confirm the association between <italic>SHP</italic> mutation and obesity [<xref rid="B101" ref-type="bibr">113</xref>, <xref rid="B102" ref-type="bibr">114</xref>]. Echwald et al. conducted an elegant study on the prevalence of <italic>SHP</italic> variants by single-strand conformational polymorphism and heteroduplex analysis among 750 Danish obese men with early-onset obesity [<xref rid="B102" ref-type="bibr">114</xref>]. As control, a cohort of 795 nonobese control subjects was genotyped using PCR-RFLP. Functional analyses of the identified coding region variants were performed in both MIN6-m9 and HepG2 cell lines. Five novel variants were identified (including 3 missense variants (c.100C&gt;G [p.R34G], c.278G&gt;A [p.G93D], and c.415C&gt;A [p.P139H]) and 2 silent variants (c.65C&gt;T [p.Y22Y] and c.339G&gt;A [p.P113P])). The previously reported [<xref rid="B99" ref-type="bibr">111</xref>] c.512G&gt;C [p.G171A] common polymorphism was identified; however, the prevalence of functional <italic>SHP</italic> variants associated with obesity was considerably lower among Danish subjects (1 out of 750 obese, none of control subjects), compared to the prevalence observed in Japan by Nishigori et al. [<xref rid="B99" ref-type="bibr">111</xref>]. Mitchell at al. [<xref rid="B101" ref-type="bibr">113</xref>] investigated SHP variants in 1927 UK subjects according to type 2 diabetes, obesity, and birth weight. Although reporting a raised body mass index among homozygous carriers of the 171A variant (&lt;1%), this polymorphism was unlikely to be associated with all three conditions in Caucasians. Taken together, the above-mentioned studies suggest that the 171A variant might contribute only to subsets of polygenic obesity.</p></sec><sec id="sec4"><title>4. Other Functions of SHP</title><p>The existence of multiple interactions of SHP with NRs, transcription factors and transcriptional cofactors (Tables <xref ref-type="table" rid="tab2">2</xref> and <xref ref-type="table" rid="tab3">3</xref>) points to the pleiotropic and central role of SHP in the body.</p><p>SHP has been hypothesized to act in glucose homeostasis via complex pathways involving the inhibition of glucocorticoid receptors (GR) in mammalian cells and the inhibition of PGC-1 gene, a coactivator of NRs important for gluconeogenic gene expression and the PGC-1-regulated phospho(enol)pyruvate carboxykinase (PEPCK) promoter. Such steps underscore a physiologically relevant role for SHP in modulating hepatic glucocorticoid action [<xref rid="B22" ref-type="bibr">22</xref>]. Following the bile acid-induced induction, SHP inhibited a number of other pathways, including the HNF4<italic>&#945;</italic>-mediated transactivation of the PEPCK and fructose biphosphate (FBP) promoters, as well as the transactivation of the glucose-6-phosphatase (G6Pase) promoter mediated by Foxo1 [<xref rid="B103" ref-type="bibr">115</xref>]. The interaction between SHP inhibitory function and the 3 isoforms (<italic>&#945;</italic>, <italic>&#946;</italic>, and <italic>&#947;</italic>) of the hepatocyte nuclear factor-3 (HNF4) points to the regulatory role of SHP on gluconeogenesis [<xref rid="B39" ref-type="bibr">51</xref>]. A role for SHP in insulin secretion pathway has also been reported. Mutations in hepatocyte nuclear factor 1<italic>&#945;</italic> (HNF-1<italic>&#945;</italic>) is associated with maturity-onset diabetes of the young type 3. This condition depends on impaired insulin secretory response in pancreatic beta cells.</p><p>Indeed, loss of HNF-1<italic>&#945;</italic> function in HNF-1<italic>&#945;</italic> (&#8722;/&#8722;) mice resulted in altered expression of genes involved in glucose-stimulated insulin secretion, but also insulin synthesis, and beta-cell differentiation. Pancreatic islets of HNF-1<italic>&#945;</italic> (&#8722;/&#8722;) mice showed a distinctive reduction of SHP expression and a downregulation of the HNF4<italic>&#945;</italic> gene expression. Since SHP appears to repress its own transcriptional activation following heterodimerization with HNF4<italic>&#945;</italic>, a feedback autoregulatory loop between SHP and HNF4<italic>&#945;</italic> has been hypothesized [<xref rid="B104" ref-type="bibr">116</xref>]. Also, SHP likely functions as a negative regulator of pancreatic islet insulin secretion. SHP (&#8722;/&#8722;) mice were characterized by hypoinsulinemia, increased glucose-dependent response of islets, increased peripheral insulin sensitivity, and increased glycogen stores [<xref rid="B105" ref-type="bibr">117</xref>]. The role played by SHP in the regulation of hepatic gluconeogenesis has also emerged in a number of additional experiments. For example, the liver of SHP (&#8722;/&#8722;) mice showed increased glycogen stores [<xref rid="B105" ref-type="bibr">117</xref>], while hepatic <italic>Shp</italic> gene expression (induced by the antidiabetic biguanide drug metformin) was associated with inhibition of hepatic gluconeogenesis. Induction of SHP was achieved via AMP-activated protein kinase (AMPK) and associated with downregulation of essential gluconeogenic enzyme genes, that is, phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase) [<xref rid="B106" ref-type="bibr">118</xref>], and fructose-1,6-bisphosphatase (FBP1) [<xref rid="B107" ref-type="bibr">119</xref>].</p><p>PGC-1 gene is a coactivator of NRs, and this step is relevant for gluconeogenic gene expression. Yamagata et al. [<xref rid="B107" ref-type="bibr">119</xref>] showed that bile acid (chenodeoxycholic acid) was able to induce the downregulation of PGC-1 gene, and this mechanism involved forkhead transcription factors (Foxo1, Foxo3a, Foxo4) via a SHP-dependent manner.</p><p>Drug metabolism and detoxification might be regulated by SHP. This is also the case for excess BAs: the pregnane X receptor (PXR) induces CYP3A and inhibits CYP7<italic>&#945;</italic>, both involved in biochemical pathways leading to the conversion of cholesterol into primary BAs, whereas CYP3A is also involved in the detoxification of toxic secondary bile acid derivatives. SHP acts as a potent repressor of PXR transactivation, and this finding suggests that PXR can act on both bile acid synthesis and elimination detoxification [<xref rid="B1" ref-type="bibr">1</xref>]. Additional mechanisms involved in the SHP-dependent control of pathways of drug metabolism have been identified. The expression of genes involved with the metabolism of xenobiotics might be regulated by SHP in the spleen acting on (aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT)) AHR/ARNT heterodimers which, in turn, bind to xenobiotic response elements (XREs) at the level of specific DNA sequences [<xref rid="B29" ref-type="bibr">41</xref>]. A number of genes involved in hormone and drug metabolism would be expressed (i.e., UGT16, ALDH3, CYP1A1, CYP1A2, CYP1B1, etc.). SHP also appears to downregulate the constitutive-androstane-receptor- (CAR-) mediated CYP2B1 gene expression, induced by phenobarbital to form the CAR/RXR heterodimer which, in turn, binds to 2 DR-4 sites to form the phenobarbital responsive unit in the CYP2B gene [<xref rid="B108" ref-type="bibr">120</xref>] (<xref ref-type="table" rid="tab3">Table 3</xref>). One role of SHP in steroidogenesis has been identified in the testes with influence on testosterone synthesis and germ cell differentiation [<xref rid="B109" ref-type="bibr">121</xref>] and in the intestine for glucocorticoid synthesis [<xref rid="B110" ref-type="bibr">122</xref>].</p><p>A role for SHP in cell proliferation and apoptosis signaling is emerging. Depending on the cell type, SHP seems to have both inhibitory and stimulatory effects on apoptosis. However, the manipulation of SHP through the synthetic ligands adamantyl-substituted retinoid-related (ARR) compounds 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437/AHPN) and 4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces apoptosis of a number of malignant cells (i.e., leukemia and breast carcinoma) both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="B111" ref-type="bibr">123</xref>, <xref rid="B112" ref-type="bibr">124</xref>]. The complex mechanism implies binding of ARR and 3-Cl-AHPC to SHP with formation of a corepressor complex containing Sin3A and nuclear receptor corepressor (<italic>N</italic>-CoR) which activate local control of mitochondrial function and apoptosis, with a limiting function on tumorigenesis [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B111" ref-type="bibr">123</xref>] (<xref ref-type="table" rid="tab3">Table 3</xref>). SHP appears to be also involved in DNA methylation and acting as a tumor suppressor, at least in the human and mouse livers [<xref rid="B113" ref-type="bibr">125</xref>&#8211;<xref rid="B115" ref-type="bibr">127</xref>]. Whether manipulation of SHP will be helpful in the treatment of hepatic and other gastrointestinal cancers is still a matter of research. The recent finding that SHP negatively regulates TLR signaling to NF-<italic>&#954;</italic>B has raised the interest for the role of SHP in mechanisms governing innate immunity. SHP appears to negatively regulate the expression of genes encoding inflammatory molecules. Of note, direct binding of NF-<italic>&#954;</italic>B seems to occur in resting cells, while binding of SHP to TRAF6 occurs in LPS-stimulated cells [<xref rid="B116" ref-type="bibr">128</xref>, <xref rid="B117" ref-type="bibr">129</xref>].</p></sec><sec id="sec5"><title>5. Conclusions and Perspectives</title><p>A remarkable number of metabolic functions in the body appear to be regulated by the orphan unique NR, small heterodimer partner SHP, which targets a complex set of genes in multiple pathways as a transcriptional corepressor (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Pathways include fatty acid metabolism, glucose homeostasis, and drug-hormone detoxification. When looking at complex mechanisms leading to some important <italic>lipidopathies, </italic>that is, obesity and liver steatosis, enlightening data about the regulatory function of SHP are provided by studies using <italic>Shp</italic>-deleted and <italic>Shp</italic>-overexpressed animal models. Most likely, a condition of <italic>Shp </italic>deficiency might counteract lipid accumulation and improve plasma lipoprotein profiles. Further studies are urgently needed to confirm that such an important metabolic regulatory mechanism of SHP is true and has high translational value. To date, however, no synthetic antagonists or agonists for SHP are available, and one should keep in mind that rather divergent and somewhat elusive data have been observed regarding the loss of SHP function in humans and rodents. Thus, careful examination of subtle SHP intrinsic functions is essential to dissect potential modulatory pathways of SHP for a variety of metabolic abnormalities but also in tumorigenesis. Moreover, identifying specific endogenous ligands and synthetic agonists of SHP will pave the way to for therapeutic intervention. The effect of synthetic ligands on SHP modulation in hepatocytes and adipocytes, for example, might represent therapeutic tools for the treatment of constituents of the metabolic syndrome, namely, hypercholesterolemia, overweight obesity, and liver steatosis.</p></sec></body><back><ack><title>Conflict of Interests</title><p> The authors declare that there is no conflict of interests.</p></ack><ack><title>Acknowledgments</title><p>This work was supported in part by research grants DK54012 and DK73917 (D. Q.-H. Wang) from the National Institutes of Health (US Public Health Service), FIRB 2003 RBAU01RANB002 (P. Portincasa) from the Italian Ministry of University and Research, and ORBA10ROPA from the University of Bari. P. Portincasa was a recipient of the short-term mobility grant 2005 from the Italian National Research Council (CNR). L. Bonfrate was a recipient of the travel grant for young investigators from the European Society for Clinical Investigation, 2011. Due to space limitations, the authors apologize to those whose publications related to the discussed issues could not be cited.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>AF1:</term><def><p>Activation function 1</p></def></def-item><def-item><term>AF2:</term><def><p>Activation function 2</p></def></def-item><def-item><term>AHR/ARNT:</term><def><p>Aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) </p></def></def-item><def-item><term>ALDH3:</term><def><p>Human aldehyde dehydrogenase 3 gene</p></def></def-item><def-item><term>AMPK:</term><def><p>AMP-activated protein kinase</p></def></def-item><def-item><term>ARR:</term><def><p>Adamantyl-substituted retinoid-related molecules</p></def></def-item><def-item><term><italic>&#946;</italic>1-AR:</term><def><p>
<italic>&#946;</italic>1-adrenergic receptor</p></def></def-item><def-item><term>BAREs:</term><def><p>Bile acids response elements</p></def></def-item><def-item><term>BAT:</term><def><p>Brown adipose tissue</p></def></def-item><def-item><term>Brm:</term><def><p>Human Brahma (a catalytic component of the SWI/SNF-related chromatin-remodeling complex) </p></def></def-item><def-item><term>CAR:</term><def><p>Constitutive androstane receptor</p></def></def-item><def-item><term>CD437/AHPN:</term><def><p>6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid</p></def></def-item><def-item><term>3-Cl-AHPC:</term><def><p>4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid</p></def></def-item><def-item><term>CYP3A:</term><def><p>Hepatic cytochrome P-4503A</p></def></def-item><def-item><term>CYP1A1:</term><def><p>Cytochrome P450, family 1, subfamily A, polypeptide 1</p></def></def-item><def-item><term>CYP1A2:</term><def><p>Cytochrome P450, family 1, subfamily A, polypeptide 2</p></def></def-item><def-item><term>CYP1B1:</term><def><p>Cytochrome P450, family 1, subfamily B, polypeptide 1</p></def></def-item><def-item><term>CYP2B1:</term><def><p>Cytochrome P450, subfamily IIB</p></def></def-item><def-item><term>CYP7A1:</term><def><p>Cholesterol 7 alpha-hydroxylase</p></def></def-item><def-item><term>CYP8B1:</term><def><p>Cholesterol 12alpha-hydroxylase</p></def></def-item><def-item><term>DBD:</term><def><p>DNA-binding domain</p></def></def-item><def-item><term>DAX-1:</term><def><p>Dosage-sensitive sex reversal adrenal hypoplasia congenita (AHC) critical region on the X chromosome, gene 1</p></def></def-item><def-item><term>DR-4:</term><def><p>Nuclear receptor half-site repeat</p></def></def-item><def-item><term>ER:</term><def><p>Estrogen receptor</p></def></def-item><def-item><term>FBP1:</term><def><p>Fructose-1,6-bisphosphatase</p></def></def-item><def-item><term>FGF:</term><def><p>Fibroblast growth factor</p></def></def-item><def-item><term>FGFR:</term><def><p>Fibroblast growth factor receptor</p></def></def-item><def-item><term>FISH:</term><def><p>Fluorescence <italic>in situ </italic>hybridization</p></def></def-item><def-item><term>Foxo:</term><def><p>Forkhead transcription factors</p></def></def-item><def-item><term>FXR:</term><def><p>Farnesoid X receptor</p></def></def-item><def-item><term>G6Pase:</term><def><p>Glucose-6-phosphatase</p></def></def-item><def-item><term>GPCR:</term><def><p>G-protein-coupled Receptor</p></def></def-item><def-item><term>GPS2:</term><def><p>G protein pathway suppressor 2</p></def></def-item><def-item><term>GR:</term><def><p>Glucocorticoid receptors</p></def></def-item><def-item><term>HDL:</term><def><p>High-density lipoprotein</p></def></def-item><def-item><term>HNF:</term><def><p>Hepatocyte nuclear factor</p></def></def-item><def-item><term>JNK:</term><def><p>Jun N-terminal kinase</p></def></def-item><def-item><term>JUN-D:</term><def><p>Jun family of the activator protein 1 (AP-1) transcription factor complex</p></def></def-item><def-item><term>LBD:</term><def><p>Ligand-binding domain</p></def></def-item><def-item><term>LDL:</term><def><p>Low-density lipoprotein</p></def></def-item><def-item><term>LDLR:</term><def><p>Low-density lipoprotein receptor</p></def></def-item><def-item><term>LRH1:</term><def><p>Liver receptor homologue 1</p></def></def-item><def-item><term>3T3-L1:</term><def><p>Mouse embryonic fibroblast adipose-like cell line.</p></def></def-item><def-item><term>LXXLL:</term><def><p>Leu-Xaa-Xaa-Leu-Leu</p></def></def-item><def-item><term>mSin3A:</term><def><p>Mammalian homolog of the Saccharomyces cerevisiae transcriptional corepressor Sin3p</p></def></def-item><def-item><term>N-CoR:</term><def><p>Nuclear receptor corepressor</p></def></def-item><def-item><term>NRs:</term><def><p>Nuclear receptors</p></def></def-item><def-item><term>PEPCK:</term><def><p>Phosphoenolpyruvate carboxykinase</p></def></def-item><def-item><term>PGC-1:</term><def><p>Peroxisome proliferator-activated receptor-<italic>&#947;</italic> (PPAR-<italic>&#947;</italic>) coactivator-1</p></def></def-item><def-item><term>PKC:</term><def><p>Protein kinase C</p></def></def-item><def-item><term>PXR:</term><def><p>Pregnane X receptor</p></def></def-item><def-item><term>RAR:</term><def><p>Retinoid acid receptor</p></def></def-item><def-item><term>RNA Pol II:</term><def><p>RNA polymerase II</p></def></def-item><def-item><term>RNF31</term><def><p>Member of the ring-between-ring (RBR) family of E3 ubiquitin ligases</p></def></def-item><def-item><term>RXR:</term><def><p>Retinoid X receptor</p></def></def-item><def-item><term>SHP:</term><def><p>Small heterodimer partner</p></def></def-item><def-item><term>SMILE:</term><def><p>SHP-interacting leucine zipper protein</p></def></def-item><def-item><term>SMRT:</term><def><p>Silencing mediator of retinoid and thyroid hormone receptor</p></def></def-item><def-item><term>SRC-1:</term><def><p>Steroid receptor coactivator-1</p></def></def-item><def-item><term>SWI/SNF:</term><def><p>SWItch/Sucrose NonFermentable (yeast nucleosome remodeling complex composed of several proteins which are products of the SWI and SNF genes) </p></def></def-item><def-item><term>UCP1:</term><def><p>Uncoupling protein-1</p></def></def-item><def-item><term>USF-1:</term><def><p>Upstream stimulatory factor-1</p></def></def-item><def-item><term>TFIID:</term><def><p>Transcription initiation factor II D</p></def></def-item><def-item><term>TFIIE:</term><def><p>Transcription factor II E</p></def></def-item><def-item><term>UGT-16:</term><def><p>Uridine 5&#8242;-diphospho (UDP) glucuronosyl transferase family member</p></def></def-item><def-item><term>VLDL:</term><def><p>Very-low-density lipoprotein</p></def></def-item><def-item><term>XREs:</term><def><p>Xenobiotic response elements</p></def></def-item><def-item><term>WAT:</term><def><p>White adipose tissue.</p></def></def-item></def-list></glossary><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ourlin</surname><given-names>JC</given-names></name><name><surname>Lasserre</surname><given-names>F</given-names></name><name><surname>Pineau</surname><given-names>T</given-names></name><etal/></person-group><article-title>The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity</article-title><source><italic>Molecular Endocrinology</italic></source><year>2003</year><volume>17</volume><issue>9</issue><fpage>1693</fpage><lpage>1703</lpage><pub-id pub-id-type="pmid">12805410</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronemeyer</surname><given-names>H</given-names></name><name><surname>Gustafsson</surname><given-names>J&#197;</given-names></name><name><surname>Laudet</surname><given-names>V</given-names></name></person-group><article-title>Principles for modulation of the nuclear receptor superfamily</article-title><source><italic>Nature Reviews Drug Discovery</italic></source><year>2004</year><volume>3</volume><issue>11</issue><fpage>950</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">15520817</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Thummel</surname><given-names>C</given-names></name><name><surname>Beato</surname><given-names>M</given-names></name><etal/></person-group><article-title>The nuclear receptor super-family: the second decade</article-title><source><italic>Cell</italic></source><year>1995</year><volume>83</volume><issue>6</issue><fpage>835</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">8521507</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name></person-group><article-title>The RXR heterodimers and orphan receptors</article-title><source><italic>Cell</italic></source><year>1995</year><volume>83</volume><issue>6</issue><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">8521508</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardee</surname><given-names>K</given-names></name><name><surname>Necakov</surname><given-names>AS</given-names></name><name><surname>Krause</surname><given-names>H</given-names></name></person-group><article-title>Nuclear receptors: small molecule sensors that coordinate growth, metabolism and reproduction</article-title><source><italic>Subcellular Biochemistry</italic></source><year>2011</year><volume>52</volume><fpage>123</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">21557081</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronemeyer</surname><given-names>H</given-names></name><name><surname>Moras</surname><given-names>D</given-names></name></person-group><article-title>How to finger DNA</article-title><source><italic>Nature</italic></source><year>1995</year><volume>375</volume><issue>6528</issue><fpage>190</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">7746310</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalli</surname><given-names>E</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><article-title>DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation</article-title><source><italic>Molecular Endocrinology</italic></source><year>2003</year><volume>17</volume><issue>8</issue><fpage>1445</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">12775766</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Sim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>YY</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name></person-group><article-title>Structure and function of the atypical orphan nuclear receptor small heterodimer partner</article-title><source><italic>International Review of Cytology</italic></source><year>2007</year><volume>261</volume><fpage>117</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">17560281</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscatelli</surname><given-names>F</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Walker</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congentia and hypogonadotropic hypogonadism</article-title><source><italic>Nature</italic></source><year>1994</year><volume>372</volume><issue>6507</issue><fpage>672</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">7990958</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seol</surname><given-names>W</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors</article-title><source><italic>Science</italic></source><year>1996</year><volume>272</volume><issue>5266</issue><fpage>1336</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">8650544</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanaria</surname><given-names>E</given-names></name><name><surname>Muscatelli</surname><given-names>F</given-names></name><name><surname>Bardoni</surname><given-names>B</given-names></name><etal/></person-group><article-title>An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita</article-title><source><italic>Nature</italic></source><year>1994</year><volume>372</volume><issue>6507</issue><fpage>635</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">7990953</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#229;vner</surname><given-names>A</given-names></name><name><surname>Sanyal</surname><given-names>S</given-names></name><name><surname>Gustafsson</surname><given-names>J-&#197;</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name></person-group><article-title>Transcriptional corepression by SHP: molecular mechanisms and physiological consequences</article-title><source><italic>Trends in Endocrinology and Metabolism</italic></source><year>2005</year><volume>16</volume><issue>10</issue><fpage>478</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">16275121</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>S-E</given-names></name><name><surname>Seok</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes</article-title><source><italic>Molecular Endocrinology</italic></source><year>2011</year><volume>25</volume><issue>7</issue><fpage>1159</fpage><lpage>1169</lpage><pub-id pub-id-type="pmid">21566081</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farhana</surname><given-names>L</given-names></name><name><surname>Dawson</surname><given-names>MI</given-names></name><name><surname>Leid</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor</article-title><source><italic>Cancer Research</italic></source><year>2007</year><volume>67</volume><issue>1</issue><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">17210713</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name></person-group><article-title>Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner</article-title><source><italic>Endocrine Journal</italic></source><year>2008</year><volume>55</volume><issue>2</issue><fpage>253</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">17984569</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giguere</surname><given-names>V</given-names></name></person-group><article-title>Orphan nuclear receptors: from gene to function</article-title><source><italic>Endocrine Reviews</italic></source><year>1999</year><volume>20</volume><issue>5</issue><fpage>689</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">10529899</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hagedorn</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Role of nuclear receptor SHP in metabolism and cancer</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2011</year><volume>1812</volume><issue>8</issue><fpage>893</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">20970497</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Structure and expression of the orphan nuclear receptor SHP gene</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1998</year><volume>273</volume><issue>23</issue><fpage>14398</fpage><lpage>14402</lpage><pub-id pub-id-type="pmid">9603951</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bookout</surname><given-names>AL</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Downes</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>RT</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name></person-group><article-title>Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network</article-title><source><italic>Cell</italic></source><year>2006</year><volume>126</volume><issue>4</issue><fpage>789</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">16923397</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Downes</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Nuclear receptor expression links the circadian clock to metabolism</article-title><source><italic>Cell</italic></source><year>2006</year><volume>126</volume><issue>4</issue><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">16923398</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>B&#229;vner</surname><given-names>A</given-names></name><name><surname>Thomsen</surname><given-names>JS</given-names></name><name><surname>F&#228;rneg&#229;rdh</surname><given-names>M</given-names></name><name><surname>Gustafsson</surname><given-names>J&#197;</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name></person-group><article-title>The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2000</year><volume>20</volume><issue>4</issue><fpage>1124</fpage><lpage>1133</lpage><pub-id pub-id-type="pmid">10648597</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgius</surname><given-names>LJ</given-names></name><name><surname>Steffensen</surname><given-names>KR</given-names></name><name><surname>Gustafsson</surname><given-names>J&#197;</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name></person-group><article-title>Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2002</year><volume>277</volume><issue>51</issue><fpage>49761</fpage><lpage>49766</lpage><pub-id pub-id-type="pmid">12324453</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobinet</surname><given-names>J</given-names></name><name><surname>Auzou</surname><given-names>G</given-names></name><name><surname>Nicolas</surname><given-names>JC</given-names></name><name><surname>Sultan</surname><given-names>C</given-names></name><name><surname>Jalaguier</surname><given-names>S</given-names></name></person-group><article-title>Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP</article-title><source><italic>Biochemistry</italic></source><year>2001</year><volume>40</volume><issue>50</issue><fpage>15369</fpage><lpage>15377</lpage><pub-id pub-id-type="pmid">11735420</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seol</surname><given-names>W</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>Novel receptor interaction and repression domains in the orphan receptor SHP</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>1997</year><volume>17</volume><issue>12</issue><fpage>7126</fpage><lpage>7131</lpage><pub-id pub-id-type="pmid">9372944</pub-id></element-citation></ref><ref id="B128"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>YB</given-names></name><name><surname>Nedumaran</surname><given-names>B</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name></person-group><article-title>Molecular characterization of SMILE as a novel corepressor of nuclear receptors</article-title><source><italic>Nucleic Acids Research</italic></source><year>2009</year><volume>37</volume><issue>12</issue><fpage>4100</fpage><lpage>4115</lpage><pub-id pub-id-type="pmid">19429690</pub-id></element-citation></ref><ref id="B129"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>YB</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor <italic>&#947;</italic> transactivation</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2009</year><volume>284</volume><issue>42</issue><fpage>28762</fpage><lpage>28774</lpage><pub-id pub-id-type="pmid">19690166</pub-id></element-citation></ref><ref id="B130"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Differential regulation of human and mouse orphan nuclear receptor small heterodimer partner promoter by sterol regulatory element binding protein-1</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>27</issue><fpage>28122</fpage><lpage>28131</lpage><pub-id pub-id-type="pmid">15123650</pub-id></element-citation></ref><ref id="B131"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>K-H</given-names></name><etal/></person-group><article-title>Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptorsmall heterodimer partner in primary hepatocytes</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2009</year><volume>284</volume><issue>42</issue><fpage>28510</fpage><lpage>28521</lpage><pub-id pub-id-type="pmid">19720831</pub-id></element-citation></ref><ref id="B132"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>A</given-names></name><etal/></person-group><article-title>Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2003</year><volume>278</volume><issue>12</issue><fpage>10214</fpage><lpage>10220</lpage><pub-id pub-id-type="pmid">12525500</pub-id></element-citation></ref><ref id="B133"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>G</given-names></name><name><surname>Renga</surname><given-names>B</given-names></name><name><surname>Antonelli</surname><given-names>E</given-names></name><name><surname>Passeri</surname><given-names>D</given-names></name><name><surname>Pellicciari</surname><given-names>R</given-names></name><name><surname>Fiorucci</surname><given-names>S</given-names></name></person-group><article-title>The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes</article-title><source><italic>Molecular Pharmacology</italic></source><year>2005</year><volume>68</volume><issue>2</issue><fpage>551</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">15911693</pub-id></element-citation></ref><ref id="B134"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isoda</surname><given-names>K</given-names></name><name><surname>Sawada</surname><given-names>S</given-names></name><name><surname>Ayaori</surname><given-names>M</given-names></name><etal/></person-group><article-title>Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2005</year><volume>280</volume><issue>8</issue><fpage>7002</fpage><lpage>7009</lpage><pub-id pub-id-type="pmid">15574426</pub-id></element-citation></ref><ref id="B135"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>MG</given-names></name><name><surname>Yoo</surname><given-names>YG</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Pak</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>MO</given-names></name></person-group><article-title>Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells</article-title><source><italic>Molecular Endocrinology</italic></source><year>2005</year><volume>19</volume><issue>4</issue><fpage>950</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">15625237</pub-id></element-citation></ref><ref id="B136"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaya</surname><given-names>E</given-names></name><name><surname>Shiraki</surname><given-names>T</given-names></name><name><surname>Jingami</surname><given-names>H</given-names></name></person-group><article-title>The nuclear bile acid receptor FXR is activated by PGC-1<italic>&#945;</italic> in a ligand-dependent manner</article-title><source><italic>Biochemical Journal</italic></source><year>2004</year><volume>382</volume><issue>3</issue><fpage>913</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">15202934</pub-id></element-citation></ref><ref id="B137"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Bas</surname><given-names>JM</given-names></name><name><surname>Fern&#225;ndez-Larrea</surname><given-names>J</given-names></name><name><surname>Blay</surname><given-names>M</given-names></name><etal/></person-group><article-title>Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats</article-title><source><italic>FASEB Journal</italic></source><year>2005</year><volume>19</volume><issue>3</issue><fpage>479</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">15637110</pub-id></element-citation></ref><ref id="B138"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Fujimori</surname><given-names>T</given-names></name><name><surname>Furuya</surname><given-names>A</given-names></name><name><surname>Satoh</surname><given-names>J</given-names></name><name><surname>Nabeshima</surname><given-names>Y</given-names></name><name><surname>Nabeshima</surname><given-names>Y-I</given-names></name></person-group><article-title>Impaired negative feedback suppression of bile acid synthesis in mice lacking <italic>&#946;</italic>Klotho</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2005</year><volume>115</volume><issue>8</issue><fpage>2202</fpage><lpage>2208</lpage><pub-id pub-id-type="pmid">16075061</pub-id></element-citation></ref><ref id="B139"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Lai</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>LJ</given-names></name><name><surname>Harnish</surname><given-names>DC</given-names></name><name><surname>Chadwick</surname><given-names>CC</given-names></name></person-group><article-title>Estrogen receptor <italic>&#945;</italic> inhibits IL-1<italic>&#946;</italic> induction of gene expression in the mouse liver</article-title><source><italic>Endocrinology</italic></source><year>2002</year><volume>143</volume><issue>7</issue><fpage>2559</fpage><lpage>2570</lpage></element-citation></ref><ref id="B25"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1</article-title><source><italic>Molecular Endocrinology</italic></source><year>2004</year><volume>18</volume><issue>5</issue><fpage>1082</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">14963109</pub-id></element-citation></ref><ref id="B26"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oiwa</surname><given-names>A</given-names></name><name><surname>Kakizawa</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2007</year><volume>353</volume><issue>4</issue><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">17204240</pub-id></element-citation></ref><ref id="B27"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>YB</given-names></name><name><surname>Lee</surname><given-names>OH</given-names></name><name><surname>Nedumaran</surname><given-names>B</given-names></name><etal/></person-group><article-title>SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation</article-title><source><italic>Biochemical Journal</italic></source><year>2008</year><volume>416</volume><issue>3</issue><fpage>463</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">18657049</pub-id></element-citation></ref><ref id="B28"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>JH</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-<italic>&#946;</italic> signaling by repressing Smad3 transactivation</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2006</year><volume>281</volume><issue>51</issue><fpage>39169</fpage><lpage>39178</lpage><pub-id pub-id-type="pmid">17074765</pub-id></element-citation></ref><ref id="B29"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinge</surname><given-names>CM</given-names></name><name><surname>Jernigan</surname><given-names>SC</given-names></name><name><surname>Risinger</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT)</article-title><source><italic>Archives of Biochemistry and Biophysics</italic></source><year>2001</year><volume>390</volume><issue>1</issue><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11368516</pub-id></element-citation></ref><ref id="B30"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>YB</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name></person-group><article-title>Transcriptional corepressor shp recruits sirt1 histone deacetylase to inhibit LRH-1 transactivation</article-title><source><italic>Nucleic Acids Research</italic></source><year>2010</year><volume>38</volume><issue>14</issue><fpage>4607</fpage><lpage>4619</lpage><pub-id pub-id-type="pmid">20375098</pub-id></element-citation></ref><ref id="B31"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlund</surname><given-names>A</given-names></name><name><surname>Anthonisen</surname><given-names>EH</given-names></name><name><surname>Gustafsson</surname><given-names>N</given-names></name><etal/></person-group><article-title>E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2009</year><volume>29</volume><issue>8</issue><fpage>2230</fpage><lpage>2242</lpage><pub-id pub-id-type="pmid">19237537</pub-id></element-citation></ref><ref id="B32"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Han</surname><given-names>CY</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><etal/></person-group><article-title>The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-<italic>&#954;</italic>B in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>36</issue><fpage>33736</fpage><lpage>33740</lpage><pub-id pub-id-type="pmid">11448950</pub-id></element-citation></ref><ref id="B33"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishizawa</surname><given-names>H</given-names></name><name><surname>Yamagata</surname><given-names>K</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name><etal/></person-group><article-title>Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor <italic>&#947;</italic> transactivation</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2002</year><volume>277</volume><issue>2</issue><fpage>1586</fpage><lpage>1592</lpage><pub-id pub-id-type="pmid">11696534</pub-id></element-citation></ref><ref id="B34"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassam</surname><given-names>A</given-names></name><name><surname>Capone</surname><given-names>JP</given-names></name><name><surname>Rachubinski</surname><given-names>RA</given-names></name></person-group><article-title>The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor <italic>&#945;</italic>-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal <italic>&#946;</italic>-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase</article-title><source><italic>Molecular and Cellular Endocrinology</italic></source><year>2001</year><volume>176</volume><issue>1-2</issue><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">11369442</pub-id></element-citation></ref><ref id="B35"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Dell</surname><given-names>H</given-names></name><name><surname>Dowhan</surname><given-names>DH</given-names></name><name><surname>Hadzopoulou-Cladaras</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2000</year><volume>20</volume><issue>1</issue><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">10594021</pub-id></element-citation></ref><ref id="B36"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2002</year><volume>277</volume><issue>4</issue><fpage>2463</fpage><lpage>2467</lpage><pub-id pub-id-type="pmid">11668176</pub-id></element-citation></ref><ref id="B37"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>Thomsen</surname><given-names>JS</given-names></name><name><surname>Damdimopoulos</surname><given-names>AE</given-names></name><name><surname>Spyrou</surname><given-names>G</given-names></name><name><surname>Gustafsson</surname><given-names>JA</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name></person-group><article-title>The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ER<italic>&#945;</italic> and ER<italic>&#946;</italic>
</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1999</year><volume>274</volume><issue>1</issue><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">9867849</pub-id></element-citation></ref><ref id="B38"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemper</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Bhalla</surname><given-names>S</given-names></name><name><surname>Bae</surname><given-names>Y</given-names></name></person-group><article-title>Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2004</year><volume>24</volume><issue>17</issue><fpage>7707</fpage><lpage>7719</lpage><pub-id pub-id-type="pmid">15314177</pub-id></element-citation></ref><ref id="B39"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/foxa transactivation via inhibition of its DNA binding</article-title><source><italic>Molecular Endocrinology</italic></source><year>2004</year><volume>18</volume><issue>12</issue><fpage>2880</fpage><lpage>2894</lpage><pub-id pub-id-type="pmid">15358835</pub-id></element-citation></ref><ref id="B40"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorucci</surname><given-names>S</given-names></name><name><surname>Antonelli</surname><given-names>E</given-names></name><name><surname>Rizzo</surname><given-names>G</given-names></name><etal/></person-group><article-title>The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis</article-title><source><italic>Gastroenterology</italic></source><year>2004</year><volume>127</volume><issue>5</issue><fpage>1497</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">15521018</pub-id></element-citation></ref><ref id="B41"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanamaluru</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Arginine methylation by PRMT5 at a naturally occurring mutation site Is critical for liver metabolic regulation by small heterodimer partner</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2011</year><volume>31</volume><issue>7</issue><fpage>1540</fpage><lpage>1550</lpage><pub-id pub-id-type="pmid">21262773</pub-id></element-citation></ref><ref id="B42"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeke</surname><given-names>MO</given-names></name><name><surname>Plass</surname><given-names>JRM</given-names></name><name><surname>Heegsma</surname><given-names>J</given-names></name><etal/></person-group><article-title>Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters</article-title><source><italic>Hepatology</italic></source><year>2009</year><volume>49</volume><issue>1</issue><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">19111018</pub-id></element-citation></ref><ref id="B43"><label>55</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sherlock</surname><given-names>S</given-names></name><name><surname>Dooley</surname><given-names>J</given-names></name></person-group><source><italic>Diseases of the Liver and Biliary System</italic></source><year>2002</year><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Blackwell Science</publisher-name></element-citation></ref><ref id="B44"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>JY</given-names></name></person-group><article-title>Regulation of bile acid synthesis</article-title><source><italic>Frontiers in Bioscience</italic></source><year>1998</year><volume>3</volume><fpage>d176</fpage><lpage>d193</lpage><pub-id pub-id-type="pmid">9450986</pub-id></element-citation></ref><ref id="B45"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Moschetta</surname><given-names>A</given-names></name><etal/></person-group><article-title>Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis</article-title><source><italic>Cell Metabolism</italic></source><year>2005</year><volume>2</volume><issue>4</issue><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16213224</pub-id></element-citation></ref><ref id="B46"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diogo</surname><given-names>CV</given-names></name><name><surname>Grattagliano</surname><given-names>I</given-names></name><name><surname>Oliveira</surname><given-names>PJ</given-names></name><name><surname>Bonfrate</surname><given-names>L</given-names></name><name><surname>Portincasa</surname><given-names>P</given-names></name></person-group><article-title>Re-wiring the circuit: mitochondria as a pharmacological target in liver disease</article-title><source><italic>Current Medicinal Chemistry</italic></source><year>2011</year><volume>18</volume><issue>35</issue><fpage>5448</fpage><lpage>5465</lpage><pub-id pub-id-type="pmid">22087837</pub-id></element-citation></ref><ref id="B47"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grattagliano</surname><given-names>I</given-names></name><name><surname>Russmann</surname><given-names>S</given-names></name><name><surname>Diogo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mitochondria in chronic liver disease</article-title><source><italic>Current Drug Targets</italic></source><year>2011</year><volume>12</volume><issue>6</issue><fpage>879</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">21269263</pub-id></element-citation></ref><ref id="B48"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>JYL</given-names></name></person-group><article-title>Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms</article-title><source><italic>Journal of Hepatology</italic></source><year>2004</year><volume>40</volume><issue>3</issue><fpage>539</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">15123373</pub-id></element-citation></ref><ref id="B49"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelinek</surname><given-names>DF</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Slaughter</surname><given-names>CA</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><article-title>Cloning and regulation of cholesterol 7<italic>&#945;</italic>-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1990</year><volume>265</volume><issue>14</issue><fpage>8190</fpage><lpage>8197</lpage><pub-id pub-id-type="pmid">2335522</pub-id></element-citation></ref><ref id="B50"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>DJ</given-names></name><name><surname>Blanchard</surname><given-names>SG</given-names></name><name><surname>Bledsoe</surname><given-names>RK</given-names></name><etal/></person-group><article-title>Bile acids: natural ligands for an orphan nuclear receptor</article-title><source><italic>Science</italic></source><year>1999</year><volume>284</volume><issue>5418</issue><fpage>1365</fpage><lpage>1368</lpage><pub-id pub-id-type="pmid">10334993</pub-id></element-citation></ref><ref id="B51"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laffitte</surname><given-names>BA</given-names></name><name><surname>Kast</surname><given-names>HR</given-names></name><name><surname>Nguyen</surname><given-names>CM</given-names></name><name><surname>Zavacki</surname><given-names>AM</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name></person-group><article-title>Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2000</year><volume>275</volume><issue>14</issue><fpage>10638</fpage><lpage>10647</lpage><pub-id pub-id-type="pmid">10744760</pub-id></element-citation></ref><ref id="B52"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Price</surname><given-names>RR</given-names></name><etal/></person-group><article-title>A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis</article-title><source><italic>Molecular Cell</italic></source><year>2000</year><volume>6</volume><issue>3</issue><fpage>517</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">11030332</pub-id></element-citation></ref><ref id="B53"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>TT</given-names></name><name><surname>Makishima</surname><given-names>M</given-names></name><name><surname>Repa</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Molecular basis for feedback regulation of bile acid synthesis by nuclear receptos</article-title><source><italic>Molecular Cell</italic></source><year>2000</year><volume>6</volume><issue>3</issue><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">11030331</pub-id></element-citation></ref><ref id="B54"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ory</surname><given-names>DS</given-names></name></person-group><article-title>Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?</article-title><source><italic>Circulation Research</italic></source><year>2004</year><volume>95</volume><issue>7</issue><fpage>660</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">15459087</pub-id></element-citation></ref><ref id="B55"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyal</surname><given-names>S</given-names></name><name><surname>B&#229;vner</surname><given-names>A</given-names></name><name><surname>Haroniti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>40</issue><fpage>15665</fpage><lpage>15670</lpage><pub-id pub-id-type="pmid">17895379</pub-id></element-citation></ref><ref id="B56"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Matozel</surname><given-names>M</given-names></name><name><surname>Boehme</surname><given-names>S</given-names></name><etal/></person-group><article-title>Overexpression of cholesterol 7<italic>&#945;</italic>-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis</article-title><source><italic>Hepatology</italic></source><year>2011</year><volume>53</volume><issue>3</issue><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">21319191</pub-id></element-citation></ref><ref id="B57"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>DQ</given-names></name><name><surname>Bussen</surname><given-names>M</given-names></name><name><surname>Sehayek</surname><given-names>E</given-names></name><etal/></person-group><article-title>Hepatocyte nuclear factor-1<italic>&#945;</italic> is an essential regulator of bile acid and plasma cholesterol metabolism</article-title><source><italic>Nature Genetics</italic></source><year>2001</year><volume>27</volume><issue>4</issue><fpage>375</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">11279518</pub-id></element-citation></ref><ref id="B58"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Bundman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Redundant pathways for negative feedback regulation of bile acid production</article-title><source><italic>Developmental Cell</italic></source><year>2002</year><volume>2</volume><issue>6</issue><fpage>721</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">12062085</pub-id></element-citation></ref><ref id="B59"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>TA</given-names></name><name><surname>Saeki</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><etal/></person-group><article-title>Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis</article-title><source><italic>Developmental Cell</italic></source><year>2002</year><volume>2</volume><issue>6</issue><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">12062084</pub-id></element-citation></ref><ref id="B60"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>S</given-names></name><name><surname>Raufman</surname><given-names>J-P</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name></person-group><article-title>Bile acids regulate cardiovascular function</article-title><source><italic>Clinical and Translational Science</italic></source><year>2011</year><volume>4</volume><issue>3</issue><fpage>210</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">21707953</pub-id></element-citation></ref><ref id="B61"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stravitz</surname><given-names>RT</given-names></name><name><surname>Rao</surname><given-names>YP</given-names></name><name><surname>Vlahcevic</surname><given-names>ZR</given-names></name><etal/></person-group><article-title>Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7<italic>&#945;</italic>-hydroxylase</article-title><source><italic>American Journal of Physiology</italic></source><year>1996</year><volume>271</volume><issue>2</issue><fpage>G293</fpage><lpage>G303</lpage><pub-id pub-id-type="pmid">8770045</pub-id></element-citation></ref><ref id="B62"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>JA</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Billin</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis</article-title><source><italic>Genes and Development</italic></source><year>2003</year><volume>17</volume><issue>13</issue><fpage>1581</fpage><lpage>1591</lpage><pub-id pub-id-type="pmid">12815072</pub-id></element-citation></ref><ref id="B63"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Fabiani</surname><given-names>E</given-names></name><name><surname>Mitro</surname><given-names>N</given-names></name><name><surname>Anzulovich</surname><given-names>AC</given-names></name><name><surname>Pinelli</surname><given-names>A</given-names></name><name><surname>Galli</surname><given-names>G</given-names></name><name><surname>Crestani</surname><given-names>M</given-names></name></person-group><article-title>The negative effects of bile acids and tumor necrosis factor-<italic>&#945;</italic> on the transcription of cholesterol 7<italic>&#945;</italic>-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>33</issue><fpage>30708</fpage><lpage>30716</lpage><pub-id pub-id-type="pmid">11402042</pub-id></element-citation></ref><ref id="B64"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Chiang</surname><given-names>JYL</given-names></name></person-group><article-title>Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7<italic>&#945;</italic>-hydroxylase gene transcription</article-title><source><italic>American Journal of Physiology</italic></source><year>2005</year><volume>288</volume><issue>51</issue><fpage>G74</fpage><lpage>G84</lpage><pub-id pub-id-type="pmid">15331348</pub-id></element-citation></ref><ref id="B65"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Jahan</surname><given-names>A</given-names></name><name><surname>Chiang</surname><given-names>JYL</given-names></name></person-group><article-title>Bile acids and cytokines inhibit the human cholesterol 7<italic>&#945;</italic>-hydroxylase gene via the JNK/c-Jun pathway in human liver cells</article-title><source><italic>Hepatology</italic></source><year>2006</year><volume>43</volume><issue>6</issue><fpage>1202</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">16729332</pub-id></element-citation></ref><ref id="B66"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>HB</given-names></name><name><surname>Lai</surname><given-names>KD</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name></person-group><article-title>Loss of small heterodimer partner expression in the liver protects against dyslipidemia</article-title><source><italic>Journal of Lipid Research</italic></source><year>2009</year><volume>50</volume><issue>2</issue><fpage>193</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">18820241</pub-id></element-citation></ref><ref id="B67"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HH</given-names></name><name><surname>Portincasa</surname><given-names>P</given-names></name><name><surname>Mendez-Sanchez</surname><given-names>N</given-names></name><name><surname>Uribe</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>DQH</given-names></name></person-group><article-title>Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones</article-title><source><italic>Gastroenterology</italic></source><year>2008</year><volume>134</volume><issue>7</issue><fpage>2101</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">18442485</pub-id></element-citation></ref><ref id="B68"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HH</given-names></name><name><surname>Portincasa</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>DQH</given-names></name></person-group><article-title>Rapid postprandial gallbladder refilling and increased turnover of bile prevent cholesterol crystallization in small heterodimer partner (SHP) knockout mice. DDW 2011, Chicago, USA</article-title><source><italic>Gastroenterology</italic></source><year>2011</year><volume>140</volume><issue>5</issue><fpage>S67</fpage><lpage>S68</lpage></element-citation></ref><ref id="B69"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorkhem</surname><given-names>I</given-names></name><name><surname>Blomstrand</surname><given-names>R</given-names></name><name><surname>Lewenhaupt</surname><given-names>A</given-names></name><name><surname>Svensson</surname><given-names>L</given-names></name></person-group><article-title>Effect of lymphatic drainage on 7<italic>&#945;</italic>-hydroxylation of cholesterol in rat liver</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>1978</year><volume>85</volume><issue>2</issue><fpage>532</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">736916</pub-id></element-citation></ref><ref id="B70"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modica</surname><given-names>S</given-names></name><name><surname>Petruzzelli</surname><given-names>M</given-names></name><name><surname>Bellafante</surname><given-names>E</given-names></name><etal/></person-group><article-title>Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis</article-title><source><italic>Gastroenterology</italic></source><year>2011</year><volume>142</volume><issue>2</issue><fpage>355</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">22057115</pub-id></element-citation></ref><ref id="B71"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Houten</surname><given-names>SM</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2004</year><volume>113</volume><issue>10</issue><fpage>1408</fpage><lpage>1418</lpage><pub-id pub-id-type="pmid">15146238</pub-id></element-citation></ref><ref id="B72"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulias</surname><given-names>K</given-names></name><name><surname>Katrakili</surname><given-names>N</given-names></name><name><surname>Bamberg</surname><given-names>K</given-names></name><name><surname>Underhill</surname><given-names>P</given-names></name><name><surname>Greenfield</surname><given-names>A</given-names></name><name><surname>Talianidis</surname><given-names>I</given-names></name></person-group><article-title>Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP</article-title><source><italic>EMBO Journal</italic></source><year>2005</year><volume>24</volume><issue>14</issue><fpage>2624</fpage><lpage>2633</lpage><pub-id pub-id-type="pmid">15973435</pub-id></element-citation></ref><ref id="B73"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsukuma</surname><given-names>KE</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Bennett</surname><given-names>MK</given-names></name><name><surname>Osborne</surname><given-names>TF</given-names></name></person-group><article-title>A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2007</year><volume>282</volume><issue>28</issue><fpage>20164</fpage><lpage>20171</lpage><pub-id pub-id-type="pmid">17522048</pub-id></element-citation></ref><ref id="B74"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Saha</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver</article-title><source><italic>Hepatology</italic></source><year>2007</year><volume>46</volume><issue>1</issue><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">17526026</pub-id></element-citation></ref><ref id="B75"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delerive</surname><given-names>P</given-names></name><name><surname>Galardi</surname><given-names>CM</given-names></name><name><surname>Bisi</surname><given-names>JE</given-names></name><name><surname>Nicodeme</surname><given-names>E</given-names></name><name><surname>Goodwin</surname><given-names>B</given-names></name></person-group><article-title>Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription</article-title><source><italic>Molecular Endocrinology</italic></source><year>2004</year><volume>18</volume><issue>10</issue><fpage>2378</fpage><lpage>2387</lpage><pub-id pub-id-type="pmid">15218078</pub-id></element-citation></ref><ref id="B76"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>CS</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>Resistance of SHP-null mice to bile acid-induced liver damage</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2003</year><volume>278</volume><issue>45</issue><fpage>44475</fpage><lpage>44481</lpage><pub-id pub-id-type="pmid">12933814</pub-id></element-citation></ref><ref id="B77"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Saha</surname><given-names>P</given-names></name><etal/></person-group><article-title>The orphan nuclear receptor SHP regulates PGC-1<italic>&#945;</italic> expression and energy production in brown adipocytes</article-title><source><italic>Cell Metabolism</italic></source><year>2005</year><volume>2</volume><issue>4</issue><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16213225</pub-id></element-citation></ref><ref id="B78"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamoto</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>J</given-names></name><name><surname>Yamagata</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>9</issue><fpage>7770</fpage><lpage>7776</lpage><pub-id pub-id-type="pmid">14672953</pub-id></element-citation></ref><ref id="B79"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Hao</surname><given-names>T</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Changes in diet and lifestyle and long-term weight gain in women and men</article-title><source><italic>New England Journal of Medicine</italic></source><year>2011</year><volume>364</volume><issue>25</issue><fpage>2392</fpage><lpage>2404</lpage><pub-id pub-id-type="pmid">21696306</pub-id></element-citation></ref><ref id="B80"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajimura</surname><given-names>S</given-names></name><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>Transcriptional control of brown fat development</article-title><source><italic>Cell Metabolism</italic></source><year>2010</year><volume>11</volume><issue>4</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">20374957</pub-id></element-citation></ref><ref id="B81"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>NJ</given-names></name><name><surname>Stock</surname><given-names>MJ</given-names></name></person-group><article-title>Effect of chronic food restriction on energy balance, thermogenic capacity, and brown-adipose-tissue activity in the rat</article-title><source><italic>Bioscience Reports</italic></source><year>1982</year><volume>2</volume><issue>8</issue><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">7139069</pub-id></element-citation></ref><ref id="B82"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>NJ</given-names></name><name><surname>Stock</surname><given-names>MJ</given-names></name></person-group><article-title>Effects of feeding a palatable &#8220;cafeteria&#8221; diet on energy balance in young and adult lean (+/?) Zucker rats</article-title><source><italic>British Journal of Nutrition</italic></source><year>1982</year><volume>47</volume><issue>3</issue><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">6952936</pub-id></element-citation></ref><ref id="B83"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>B</given-names></name><name><surname>Nedergaard</surname><given-names>J</given-names></name></person-group><article-title>Developmental biology: neither fat nor flesh</article-title><source><italic>Nature</italic></source><year>2008</year><volume>454</volume><issue>7207</issue><fpage>947</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">18719573</pub-id></element-citation></ref><ref id="B84"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Bjork</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><etal/></person-group><article-title>PRDM16 controls a brown fat/skeletal muscle switch</article-title><source><italic>Nature</italic></source><year>2008</year><volume>454</volume><issue>7207</issue><fpage>961</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">18719582</pub-id></element-citation></ref><ref id="B85"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klingenspor</surname><given-names>M</given-names></name></person-group><article-title>Cold-induced recruitment of brown adipose tissue thermogenesis</article-title><source><italic>Experimental Physiology</italic></source><year>2003</year><volume>88</volume><issue>1</issue><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">12525862</pub-id></element-citation></ref><ref id="B86"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trayhurn</surname><given-names>P</given-names></name></person-group><article-title>Adipose tissue in obesity&#8212;an inflammatory issue</article-title><source><italic>Endocrinology</italic></source><year>2005</year><volume>146</volume><issue>3</issue><fpage>1003</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">15713941</pub-id></element-citation></ref><ref id="B87"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trayhurn</surname><given-names>P</given-names></name><name><surname>Wood</surname><given-names>IS</given-names></name></person-group><article-title>Signalling role of adipose tissue: adipokines and inflammation in obesity</article-title><source><italic>Biochemical Society Transactions</italic></source><year>2005</year><volume>33</volume><issue>5</issue><fpage>1078</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">16246049</pub-id></element-citation></ref><ref id="B88"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>IS</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jenkins</surname><given-names>JR</given-names></name><name><surname>Trayhurn</surname><given-names>P</given-names></name></person-group><article-title>The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNF<italic>&#945;</italic> in human adipocytes</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2005</year><volume>337</volume><issue>2</issue><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">16188228</pub-id></element-citation></ref><ref id="B89"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Marken Lichtenbelt</surname><given-names>WD</given-names></name><name><surname>Vanhommerig</surname><given-names>JW</given-names></name><name><surname>Smulders</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Cold-activated brown adipose tissue in healthy men</article-title><source><italic>New England Journal of Medicine</italic></source><year>2009</year><volume>360</volume><issue>15</issue><fpage>1500</fpage><lpage>1508</lpage><pub-id pub-id-type="pmid">19357405</pub-id></element-citation></ref><ref id="B90"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>Towards a molecular understanding of adaptive thermogenesis</article-title><source><italic>Nature</italic></source><year>2000</year><volume>404</volume><issue>6778</issue><fpage>652</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">10766252</pub-id></element-citation></ref><ref id="B91"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>JD</given-names></name></person-group><article-title>PGC-1 coactivators in the control of energy metabolism</article-title><source><italic>Acta Biochimica et Biophysica Sinica</italic></source><year>2011</year><volume>43</volume><issue>4</issue><fpage>248</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">21325336</pub-id></element-citation></ref><ref id="B92"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>JA</given-names></name><name><surname>Cadenas</surname><given-names>S</given-names></name><name><surname>Jekabsons</surname><given-names>MB</given-names></name><name><surname>Roussel</surname><given-names>D</given-names></name><name><surname>Brand</surname><given-names>MD</given-names></name></person-group><article-title>Mitochondrial proton leak and the uncoupling protein 1 homologues</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2001</year><volume>1504</volume><issue>1</issue><fpage>144</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">11239491</pub-id></element-citation></ref><ref id="B93"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garruti</surname><given-names>G</given-names></name><name><surname>Ricquier</surname><given-names>D</given-names></name></person-group><article-title>Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans</article-title><source><italic>International Journal of Obesity</italic></source><year>1992</year><volume>16</volume><issue>5</issue><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">1319974</pub-id></element-citation></ref><ref id="B94"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouillaud</surname><given-names>F</given-names></name><name><surname>Villarroya</surname><given-names>F</given-names></name><name><surname>Hentz</surname><given-names>E</given-names></name><name><surname>Raimbault</surname><given-names>S</given-names></name><name><surname>Cassard</surname><given-names>AM</given-names></name><name><surname>Ricquier</surname><given-names>D</given-names></name></person-group><article-title>Detection of brown adipose tissue uncoupling protein mRNA in adult patients by a human genomic probe</article-title><source><italic>Clinical Science</italic></source><year>1988</year><volume>75</volume><issue>1</issue><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">3165741</pub-id></element-citation></ref><ref id="B95"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabbi-Anneni</surname><given-names>I</given-names></name><name><surname>Cooksey</surname><given-names>R</given-names></name><name><surname>Gunda</surname><given-names>V</given-names></name><etal/></person-group><article-title>Overexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesis</article-title><source><italic>American Journal of Physiology</italic></source><year>2010</year><volume>298</volume><issue>5</issue><fpage>E961</fpage><lpage>E970</lpage><pub-id pub-id-type="pmid">20124506</pub-id></element-citation></ref><ref id="B96"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis</article-title><source><italic>International Journal of Clinical and Experimental Pathology</italic></source><year>2009</year><volume>2</volume><issue>3</issue><fpage>275</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">19079622</pub-id></element-citation></ref><ref id="B97"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Hegele</surname><given-names>RA</given-names></name></person-group><article-title>Identification of polymorphisms in the human SHP1 gene</article-title><source><italic>Journal of Human Genetics</italic></source><year>2002</year><volume>47</volume><issue>8</issue><fpage>445</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">12181644</pub-id></element-citation></ref><ref id="B98"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>CCC</given-names></name><name><surname>Farooqi</surname><given-names>IS</given-names></name><name><surname>Ong</surname><given-names>K</given-names></name><etal/></person-group><article-title>Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations</article-title><source><italic>Diabetes</italic></source><year>2003</year><volume>52</volume><issue>5</issue><fpage>1288</fpage><lpage>1291</lpage><pub-id pub-id-type="pmid">12716767</pub-id></element-citation></ref><ref id="B99"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishigori</surname><given-names>H</given-names></name><name><surname>Tomura</surname><given-names>H</given-names></name><name><surname>Tonooka</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2001</year><volume>98</volume><issue>2</issue><fpage>575</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">11136233</pub-id></element-citation></ref><ref id="B100"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enya</surname><given-names>M</given-names></name><name><surname>Horikawa</surname><given-names>Y</given-names></name><name><surname>Kuroda</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mutations in the small heterodimer partner gene increase morbidity risk in Japanese type 2 diabetes patients</article-title><source><italic>Human Mutation</italic></source><year>2008</year><volume>29</volume><issue>11</issue><fpage>E271</fpage><lpage>E277</lpage><pub-id pub-id-type="pmid">18781616</pub-id></element-citation></ref><ref id="B101"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>SMS</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. subjects</article-title><source><italic>Diabetes</italic></source><year>2003</year><volume>52</volume><issue>5</issue><fpage>1276</fpage><lpage>1279</lpage><pub-id pub-id-type="pmid">12716764</pub-id></element-citation></ref><ref id="B102"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echwald</surname><given-names>SM</given-names></name><name><surname>Andersen</surname><given-names>KL</given-names></name><name><surname>S&#248;rensen</surname><given-names>TIA</given-names></name><etal/></person-group><article-title>Mutation analysis of NROB2 among 1545 danish men identifies a novel c.278G &gt; a (p.G93D) variant with reduced functional activity</article-title><source><italic>Human Mutation</italic></source><year>2004</year><volume>24</volume><issue>5</issue><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">15459958</pub-id></element-citation></ref><ref id="B103"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagata</surname><given-names>K</given-names></name><name><surname>Daitoku</surname><given-names>H</given-names></name><name><surname>Shimamoto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>22</issue><fpage>23158</fpage><lpage>23165</lpage><pub-id pub-id-type="pmid">15047713</pub-id></element-citation></ref><ref id="B104"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>DQ</given-names></name><name><surname>Screenan</surname><given-names>S</given-names></name><name><surname>Munoz</surname><given-names>KN</given-names></name><etal/></person-group><article-title>Loss of HNF-1<italic>&#945;</italic> function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism</article-title><source><italic>Diabetes</italic></source><year>2001</year><volume>50</volume><issue>7-12</issue><fpage>2472</fpage><lpage>2480</lpage><pub-id pub-id-type="pmid">11679424</pub-id></element-citation></ref><ref id="B105"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Saha</surname><given-names>P</given-names></name><etal/></person-group><article-title>Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis</article-title><source><italic>Molecular Endocrinology</italic></source><year>2006</year><volume>20</volume><issue>11</issue><fpage>2671</fpage><lpage>2681</lpage><pub-id pub-id-type="pmid">16803864</pub-id></element-citation></ref><ref id="B106"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YD</given-names></name><name><surname>Park</surname><given-names>KG</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP</article-title><source><italic>Diabetes</italic></source><year>2008</year><volume>57</volume><issue>2</issue><fpage>306</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">17909097</pub-id></element-citation></ref><ref id="B107"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagata</surname><given-names>K</given-names></name><name><surname>Yoshimochi</surname><given-names>K</given-names></name><name><surname>Daitoku</surname><given-names>H</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Fukamizu</surname><given-names>A</given-names></name></person-group><article-title>Bile acid represses the peroxisome proliferator-activated receptor-<italic>&#947;</italic> coactivator-1 promoter activity in a small heterodimer partner-dependent manner</article-title><source><italic>International Journal of Molecular Medicine</italic></source><year>2007</year><volume>19</volume><issue>5</issue><fpage>751</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">17390079</pub-id></element-citation></ref><ref id="B108"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>Y</given-names></name><name><surname>Kemper</surname><given-names>JK</given-names></name><name><surname>Kemper</surname><given-names>B</given-names></name></person-group><article-title>Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP)</article-title><source><italic>DNA and Cell Biology</italic></source><year>2004</year><volume>23</volume><issue>2</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15000748</pub-id></element-citation></ref><ref id="B109"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volle</surname><given-names>DH</given-names></name><name><surname>Duggavathi</surname><given-names>R</given-names></name><name><surname>Magnier</surname><given-names>BC</given-names></name><etal/></person-group><article-title>The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice</article-title><source><italic>Genes and Development</italic></source><year>2007</year><volume>21</volume><issue>3</issue><fpage>303</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">17289919</pub-id></element-citation></ref><ref id="B110"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>M</given-names></name><name><surname>Atanasov</surname><given-names>A</given-names></name><name><surname>Cima</surname><given-names>I</given-names></name><name><surname>Corazza</surname><given-names>N</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name><name><surname>Brunner</surname><given-names>T</given-names></name></person-group><article-title>Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines</article-title><source><italic>Endocrinology</italic></source><year>2007</year><volume>148</volume><issue>3</issue><fpage>1445</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">17170096</pub-id></element-citation></ref><ref id="B111"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Nuclear receptor small heterodimer partner in apoptosis signaling and liver cancer</article-title><source><italic>Cancers</italic></source><year>2011</year><volume>3</volume><issue>1</issue><fpage>198</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">24212613</pub-id></element-citation></ref><ref id="B112"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><etal/></person-group><article-title>Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2010</year><volume>30</volume><issue>6</issue><fpage>1341</fpage><lpage>1356</lpage><pub-id pub-id-type="pmid">20065042</pub-id></element-citation></ref><ref id="B113"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YY</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name></person-group><article-title>Systems-level analysis of gene expression data revealed NR0B2/SHP as potential tumor suppressor in human liver cancer</article-title><source><italic>Molecules and Cells</italic></source><year>2010</year><volume>30</volume><issue>5</issue><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">20853064</pub-id></element-citation></ref><ref id="B114"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation</article-title><source><italic>Hepatology</italic></source><year>2008</year><volume>48</volume><issue>1</issue><fpage>289</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">18537191</pub-id></element-citation></ref><ref id="B115"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth</article-title><source><italic>Gastroenterology</italic></source><year>2008</year><volume>134</volume><issue>3</issue><fpage>793</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">18325392</pub-id></element-citation></ref><ref id="B116"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuk</surname><given-names>J-M</given-names></name><name><surname>Shin</surname><given-names>D-M</given-names></name><name><surname>Lee</surname><given-names>H-M</given-names></name><etal/></person-group><article-title>The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors</article-title><source><italic>Nature Immunology</italic></source><year>2011</year><volume>12</volume><issue>8</issue><fpage>742</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">21725320</pub-id></element-citation></ref><ref id="B117"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyaert</surname><given-names>R</given-names></name></person-group><article-title>SHP works a double shift to control TLR signaling</article-title><source><italic>Nature Immunology</italic></source><year>2011</year><volume>12</volume><issue>8</issue><fpage>725</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">21772282</pub-id></element-citation></ref><ref id="B118"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>AI</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name></person-group><article-title>Retinoid X receptor heterodimers in the metabolic syndrome</article-title><source><italic>New England Journal of Medicine</italic></source><year>2005</year><volume>353</volume><issue>6</issue><fpage>604</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">16093469</pub-id></element-citation></ref><ref id="B153"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Role of small heterodimer partner in lipid homeostasis and its potential as a therapeutic target for obesity</article-title><source><italic>Clinical Lipidology</italic></source><year>2010</year><volume>5</volume><issue>4</issue><fpage>445</fpage><lpage>448</lpage></element-citation></ref><ref id="B119"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimaki-Mogami</surname><given-names>T</given-names></name><name><surname>Une</surname><given-names>M</given-names></name><name><surname>Fujino</surname><given-names>T</given-names></name><etal/></person-group><article-title>Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor</article-title><source><italic>Journal of Lipid Research</italic></source><year>2004</year><volume>45</volume><issue>8</issue><fpage>1538</fpage><lpage>1545</lpage><pub-id pub-id-type="pmid">15145977</pub-id></element-citation></ref><ref id="B120"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyal</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Differential regulation of the orphan nuclear receptor Small Heterodimer Partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2002</year><volume>277</volume><issue>3</issue><fpage>1739</fpage><lpage>1748</lpage><pub-id pub-id-type="pmid">11705994</pub-id></element-citation></ref><ref id="B121"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>K</given-names></name><name><surname>Harnish</surname><given-names>DC</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name></person-group><article-title>Estrogen receptor <italic>&#945;</italic> regulates expression of the orphan receptor small heterodimer partner</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2003</year><volume>278</volume><issue>38</issue><fpage>36418</fpage><lpage>36429</lpage><pub-id pub-id-type="pmid">12842887</pub-id></element-citation></ref><ref id="B122"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>B</given-names></name><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Kemper</surname><given-names>JK</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name></person-group><article-title>Differential regulation of rat and human CYP7A 1 by the nuclear oxysterol receptor liver X receptor-<italic>&#945;</italic>
</article-title><source><italic>Molecular Endocrinology</italic></source><year>2003</year><volume>17</volume><issue>3</issue><fpage>386</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">12554795</pub-id></element-citation></ref><ref id="B123"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name></person-group><article-title>Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1999</year><volume>274</volume><issue>30</issue><fpage>20869</fpage><lpage>20873</lpage><pub-id pub-id-type="pmid">10409629</pub-id></element-citation></ref><ref id="B124"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H-i</given-names></name><name><surname>Koh</surname><given-names>Y-K</given-names></name><name><surname>Kim</surname><given-names>T-H</given-names></name><etal/></person-group><article-title>Transcriptional activation of SHP by PPAR-<italic>&#947;</italic> in liver</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2007</year><volume>360</volume><issue>2</issue><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">17601490</pub-id></element-citation></ref><ref id="B125"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>YY</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name></person-group><article-title>Synergistic activation of the human orphan nuclear receptor SHP gene promoter by basic helix-loop-helix protein E2A and orphan nuclear receptor SF-1</article-title><source><italic>Nucleic Acids Research</italic></source><year>2003</year><volume>31</volume><issue>23</issue><fpage>6860</fpage><lpage>6872</lpage><pub-id pub-id-type="pmid">14627819</pub-id></element-citation></ref><ref id="B126"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Stravitz</surname><given-names>RT</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name><name><surname>Hylemon</surname><given-names>PB</given-names></name></person-group><article-title>Down-regulation of cholesterol 7<italic>&#945;</italic>-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>19</issue><fpage>15816</fpage><lpage>15822</lpage><pub-id pub-id-type="pmid">11278771</pub-id></element-citation></ref><ref id="B127"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Cheong</surname><given-names>J</given-names></name></person-group><article-title>The orphan nuclear receptor SHP is involved in monocytic differentiation, and its expression is increased by c-Jun</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2004</year><volume>76</volume><issue>5</issue><fpage>1082</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">15292277</pub-id></element-citation></ref><ref id="B140"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>AK</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>McCabe</surname><given-names>ERB</given-names></name></person-group><article-title>Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and Small Heterodimer Partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers</article-title><source><italic>Molecular Endocrinology</italic></source><year>2006</year><volume>20</volume><issue>10</issue><fpage>2326</fpage><lpage>2342</lpage><pub-id pub-id-type="pmid">16709599</pub-id></element-citation></ref><ref id="B141"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>AK</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>McCabe</surname><given-names>ERB</given-names></name></person-group><article-title>LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization</article-title><source><italic>Molecular Genetics and Metabolism</italic></source><year>2007</year><volume>92</volume><issue>1-2</issue><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">17686645</pub-id></element-citation></ref><ref id="B142"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinge</surname><given-names>CM</given-names></name><name><surname>Jernigan</surname><given-names>SC</given-names></name><name><surname>Risinger</surname><given-names>KE</given-names></name></person-group><article-title>The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells</article-title><source><italic>Endocrinology</italic></source><year>2002</year><volume>143</volume><issue>3</issue><fpage>853</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">11861507</pub-id></element-citation></ref><ref id="B143"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brendel</surname><given-names>C</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name><name><surname>Botrugno</surname><given-names>OA</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>The small heterodimer partner interacts with the liver X receptor <italic>&#945;</italic> and represses its transcriptional activity</article-title><source><italic>Molecular Endocrinology</italic></source><year>2002</year><volume>16</volume><issue>9</issue><fpage>2065</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">12198243</pub-id></element-citation></ref><ref id="B144"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kress</surname><given-names>S</given-names></name><name><surname>Greenlee</surname><given-names>WF</given-names></name></person-group><article-title>Cell-specific regulation of human CYP1A1 and CYP1B1 genes</article-title><source><italic>Cancer Research</italic></source><year>1997</year><volume>57</volume><issue>7</issue><fpage>1264</fpage><lpage>1269</lpage><pub-id pub-id-type="pmid">9102211</pub-id></element-citation></ref><ref id="B145"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naya</surname><given-names>FJ</given-names></name><name><surname>Stellrecht</surname><given-names>CMM</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name></person-group><article-title>Tissue-specific regulation of the insulin gene by a novel basic helix- loop-helix transcription factor</article-title><source><italic>Genes and Development</italic></source><year>1995</year><volume>9</volume><issue>8</issue><fpage>1009</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">7774807</pub-id></element-citation></ref><ref id="B146"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Hollenberg</surname><given-names>SM</given-names></name><name><surname>Snider</surname><given-names>L</given-names></name><name><surname>Turner</surname><given-names>DL</given-names></name><name><surname>Lipnick</surname><given-names>N</given-names></name><name><surname>Weintraub</surname><given-names>H</given-names></name></person-group><article-title>Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein</article-title><source><italic>Science</italic></source><year>1995</year><volume>268</volume><issue>5212</issue><fpage>836</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">7754368</pub-id></element-citation></ref><ref id="B147"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Chu</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/NeuroD</article-title><source><italic>Molecular Endocrinology</italic></source><year>2004</year><volume>18</volume><issue>4</issue><fpage>776</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">14752053</pub-id></element-citation></ref><ref id="B148"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>MJ</given-names></name><name><surname>Kong</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>HH</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Cheong</surname><given-names>JH</given-names></name></person-group><article-title>Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBP<italic>&#945;</italic>
</article-title><source><italic>Biochemical Journal</italic></source><year>2007</year><volume>402</volume><issue>3</issue><fpage>567</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">17094771</pub-id></element-citation></ref><ref id="B149"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#229;vner</surname><given-names>A</given-names></name><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>Toresson</surname><given-names>G</given-names></name><name><surname>Gustafsson</surname><given-names>J&#197;</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name></person-group><article-title>A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP</article-title><source><italic>EMBO Reports</italic></source><year>2002</year><volume>3</volume><issue>5</issue><fpage>478</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">11964378</pub-id></element-citation></ref><ref id="B150"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulias</surname><given-names>K</given-names></name><name><surname>Talianidis</surname><given-names>I</given-names></name></person-group><article-title>Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression</article-title><source><italic>Nucleic Acids Research</italic></source><year>2004</year><volume>32</volume><issue>20</issue><fpage>6096</fpage><lpage>6103</lpage><pub-id pub-id-type="pmid">15550569</pub-id></element-citation></ref><ref id="B151"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Ponugoti</surname><given-names>B</given-names></name><name><surname>Treuter</surname><given-names>E</given-names></name><name><surname>Kemper</surname><given-names>JK</given-names></name></person-group><article-title>Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2007</year><volume>27</volume><issue>4</issue><fpage>1407</fpage><lpage>1424</lpage><pub-id pub-id-type="pmid">17145766</pub-id></element-citation></ref><ref id="B152"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism</article-title><source><italic>PLoS ONE</italic></source><year>2009</year><volume>4</volume><issue>9</issue><comment>Article ID e6880.</comment></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Top: the genomic structure of human SHP. Rectangles represent the two exons with a single intron spanning approximately 1.8 kilobases and located on a single locus on chromosome 1p36.1 [<xref rid="B18" ref-type="bibr">18</xref>]. The region 5&#8242; includes <italic>&#8776;</italic>600 nucleotides from the transcription start site and is characterized by promoter activity. Bottom: typical nuclear receptor is compared with the domain structure of human SHP. The canonical structure of NR includes the N-terminal activation function 1 (AF1) domain, DNA-binding domain (DBD), ligand-binding domain (LBD), and C-terminal activation function 2 (AF2) domain. SHP lacks the DBD. Two functional LXXLL-related motifs (also named as NR boxes) are typical of the human SHP structural domains. Such motifs are located in the putative N-terminal helix 1 of the LBD and in the C-terminal region of the helix 5. While active NRs exhibit glutamic acid in AF-2, the SHP AF-2 domain is replaced with aspartic acid. Adapted from Chanda et al. [<xref rid="B15" ref-type="bibr">15</xref>] and Shulman and Mangelsdorf [<xref rid="B118" ref-type="bibr">130</xref>].</p></caption><graphic xlink:href="JL2012-304292.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>The SHP-mediated repression of target transcription factors occurs by at least three distinct transcriptional repression mechanism: (a) direct interference with the AF-2 coactivator domain of NRs (competition for coactivator binding, leading to the repression of NR-mediated transcriptional activity); (b) recruitment of corepressors, resulting in active repression; (c) direct interaction with the surface of NR or transcription factor, resulting in the blockade of DNA binding and the consequent inhibition of its transcriptional activity. See text for details. The dotted arrows and (-) symbols indicate inhibition. CoA: coactivator; CoR: corepressor; NR: nuclear receptor; SHP: small heterodimer factor; TF: transcription factor. Modified after [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B153" ref-type="bibr">131</xref>].</p></caption><graphic xlink:href="JL2012-304292.002"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>The potential molecular mechanisms of crosstalk between nuclear receptors LXR and FXR&#8211;SHP&#8211;LRH-1 regulatory cascade in the liver and intestine. Bile acids act as ligands for FXR, which regulates transcription by binding as a heterodimer with RXRs. This step results in increased SHP expression. SHP in turn inhibits LRH-1, preventing the activation of target genes that participate in bile acid and fatty acid synthesis. In the absence of bile acids, LRH-1 acts together with LXR to stimulate bile acid synthesis [<xref rid="B52" ref-type="bibr">64</xref>, <xref rid="B53" ref-type="bibr">65</xref>, <xref rid="B119" ref-type="bibr">132</xref>]. The important pathways in the intestine that contribute to modulation of bile acid synthesis are also depicted (see text for details). There is a bile-acid-mediated activation of intestinal FXR and, as a result, the release of FGF15 in the small intestine. The secreted FGF15 by the intestine circulates to the liver, likely through the portal circulation or lymph flow [<xref rid="B69" ref-type="bibr">81</xref>] and induces the activation of FGFR4 in the liver. The FGF15/FGFR4 pathway synergizes with SHP <italic>in vivo</italic> to repress CYP7A1 expression [<xref rid="B45" ref-type="bibr">57</xref>]. Bas: bile acids; FGF: fibroblast growth factor; FGFR4: FGF receptor; FXR: farnesoid X receptor; LRH-1: liver receptor homologue-1; LXR: liver X receptor; RXR: retinoid X receptors; SHP: short heterodimer partner. Adapted from Ory [<xref rid="B54" ref-type="bibr">66</xref>] and Inagaki et al. [<xref rid="B45" ref-type="bibr">57</xref>]. </p></caption><graphic xlink:href="JL2012-304292.003"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Schematic diagram of the function and gene regulation of SHP. Different conditions will lead to activation of nuclear receptors and/or transcription factors able to regulate <italic>Shp</italic> gene expression in the nucleus and protein synthesis in the cytoplasm. The protein acts as a transcriptional corepressor of a number of other nuclear receptors and transcription factors involved in a wide series of regulatory pathways. The potential role of a feedback mechanism and of ligand(s) is hypothesized.</p></caption><graphic xlink:href="JL2012-304292.004"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Small heterodimer partner (SHP) expression [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B21" ref-type="bibr">21</xref>].</p></caption><table-wrap-foot><fn><p>All organs in the mouse. Astericks indicate SHP expression in humans [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B120" ref-type="bibr">133</xref>].</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>Regulators of the Shp gene promoter [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">39</xref>&#8211;<xref rid="B31" ref-type="bibr">43</xref>].</p></caption><table-wrap-foot><fn><p>AP-1: adaptor protein-1; bHLH: basic helix-loop-helix; DAX1: dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1; E2A: E2A2 gene products belonging to the basic helix-loop-helix (bHLH) family of transcriptor factors; ER<italic>&#945;</italic>: estrogen receptor<italic>&#945;</italic>; ERR<italic>&#947;</italic>: estrogen receptor-related receptor-<italic>&#947;</italic>; FXR: farnesoid X receptor; HGF: Hepatocyte growth factor; HNF-1<italic>&#945;</italic>: hepatocyte nuclear factor-1<italic>&#945;</italic>; HNF4<italic>&#945;</italic>: hepatocyte nuclear factor-4<italic>&#945;</italic>; Id: inhibitor of differentiation; IL-1Ra (&#8722;/&#8722;): interleukin-1 receptor antagonist; JNK: Jun N-terminal kinase; LRH-1: liver receptor homologue-1; LXR<italic>&#945;</italic>: liver X receptor<italic>&#945;</italic>; NF<italic>&#954;</italic>B: nuclear factor-<italic>&#954;</italic>B; NR: nuclear receptor; NTCP: Na<sup>+</sup>-taurocholate cotransport peptide; oxLDL: oxidized low-density lipoprotein; PGC-1: PPAR<italic>&#947;</italic> (peroxisome-proliferator-activated receptor <italic>&#947;</italic>) coactivator-1<italic>&#945;</italic>; PMRT1: protein arginine methyltransferase type 1; PPRE: PPAR response element; RNF31: member of the ring-between-ring (RBR) family of E3 ubiquitin ligases; RXR <italic>&#945;</italic>: retinoid X receptor; SF-1: steroidogenic factor-1; SHP: small (short) heterodimer partner; hSHP: human small (short) heterodimer partner; SMILE: SHP-interacting leucine zipper protein; SRC-1: steroid receptor coactivator-1; SREBP-1: sterol regulatory element binding protein-1; USF-1: upstream stimulatory factor-1.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" position="float"><label>Table 3</label><caption><p>SHP targets [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">39</xref>&#8211;<xref rid="B31" ref-type="bibr">43</xref>].</p></caption><table-wrap-foot><fn><p>ABCA1, ABCG1, ABCG5, and ABCG8: ATP-binding cassette transporters; AP1: transcription factor activator protein 1; AHR: aryl hydrocarbon receptor (AHR); ARNT: aryl hydrocarbon receptor (AHR)/AHR nuclear translocator protein; ANG: angiotensin; AOx, acyl-CoA oxidase; ApoE: apolipoprotein E; bHLH-PAS: basic helix&#8211;loop&#8211;helix&#8211;PAS; AR: androgen receptor; BAFs: Brm- or Brg-1-associated factors; BARE: bile acid response element; Brm: human Brahma; CAR: constitutive androstane receptor; CBP: CREB-binding protein; C/EBP<italic>&#945;</italic>: CCAAT/enhancer-binding protein <italic>&#945;</italic>; CETP: cholesteryl ester transfer protein; CREB: coactivator cAMP-response element-binding protein; CYP7A1: cholesterol-7-<italic>&#945;</italic>-hydroxylase; DAX1: dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome: gene 1; DBD: DNA-binding domain; 6-ECDCA, 6-ethylchenodeoxycholic acid; EID1: E1A-like inhibitor of differentiation 1; ER: estrogen receptor; ERR<italic>&#947;</italic>: estrogen receptor-related receptor-<italic>&#947;</italic>; FBP1: fructose-1,6-bisphosphatase; FXR: farnesoid X receptor; G6Pase: glucose-6-phosphase; GR: glucocorticoid receptor; GPS2: G protein pathway suppressor 2; HD: enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase; HDACs: histone deacetylases; HDAC-1: histone deacetylase-1; HDAC-1: histone deacetylase-3; JunD: predominat Jun family protein; HNF3/Foxa: hepatocyte nuclear factor-3; HNF4: hepatocyte nuclear factor-4; LPS: lipopolysaccharides; LXR<italic>&#945;</italic>: liver X receptor<italic>&#945;</italic>; LRH-1: liver receptor homologue-1; miRNAs (miR): microRNAs; NcoR: nuclear receptor corepressor; NF-<italic>&#954;</italic>B: nuclear factor-<italic>&#954;</italic>B; Nur77: nuclear growth factor I-B; PEPCK: phosphoenolpyruvate carboxykinase; PPRE: peroxisome proliferator-response elements; PXR: pregnane X receptors RAR: retinoid acid receptor; RNA Pol II: RNA polymerase II; RXR: retinoid X receptor; SIRT1: sirtuin1; SREBP-1c: sterol regulatory element-binding protein-1c; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TFIID: transcription initiation factor II D (TFIID); TFIIE: transcription factor II E; TGF-<italic>&#946;</italic>: transforming growth factor-<italic>&#946;</italic>; TLRs: Toll-like receptors; TR: thyroid receptor; TRAF6: TNF-receptor-associated factor-6; XRE, xenobiotic response element; YY1: Ying Yang 1.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" position="float"><label>Table 4</label><caption><p>Studies on the association between <italic>SHP (NR0B2) </italic>genetic variation and birth weight, high BMI obesity, and fasting insulin diabetes.</p></caption><table-wrap-foot><fn><p>Note: SHP is expressed in the liver, pancreas, spleen, small intestine, and adrenal gland in humans [<xref rid="B18" ref-type="bibr">18</xref>] and inhibits the transcriptional activity of hepatocyte nuclear factor-4 <italic>&#945;</italic> (HNF4<italic>&#945;</italic>). ALSPAC: Avon Longitudinal Study of Parents and Children; GOOS: Genetics of Obesity Study; HNF4<italic>&#945;</italic>: hepatocyte nuclear factor-4<italic>&#945;</italic>.</p></fn></table-wrap-foot></table-wrap></floats-group></article>